<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006864" GROUP_ID="MUSKEL" ID="537002011515573354" MERGED_FROM="" MODIFIED="2008-06-11 03:01:34 +0200" MODIFIED_BY="Lara Maxwell" REVIEW_NO="C009-R" REVMAN_SUB_VERSION="5.0.11" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="2.0">
<COVER_SHEET MODIFIED="2008-06-10 20:55:18 -0400" MODIFIED_BY="Lara Maxwell">
<TITLE>Balneotherapy for osteoarthritis</TITLE>
<CONTACT>
<PERSON ID="5658" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Arianne</FIRST_NAME>
<MIDDLE_INITIALS>P</MIDDLE_INITIALS>
<LAST_NAME>Verhagen</LAST_NAME>
<SUFFIX>PhD</SUFFIX>
<POSITION>Associate Professor</POSITION>
<EMAIL_1>a.verhagen@erasmusmc.nl</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of General Practice</DEPARTMENT>
<ORGANISATION>Erasmus University Medical Centre</ORGANISATION>
<ADDRESS_1>PO Box 1738</ADDRESS_1>
<ADDRESS_2/>
<CITY>3000 DR Rotterdam</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<PHONE_1>+31 10 7044109</PHONE_1>
<PHONE_2/>
<FAX_1>+31 10 7040003</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2008-06-10 20:55:18 -0400" MODIFIED_BY="Lara Maxwell">
<PERSON ID="5658" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Arianne</FIRST_NAME>
<MIDDLE_INITIALS>P</MIDDLE_INITIALS>
<LAST_NAME>Verhagen</LAST_NAME>
<SUFFIX>PhD</SUFFIX>
<POSITION>Associate Professor</POSITION>
<EMAIL_1>a.verhagen@erasmusmc.nl</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of General Practice</DEPARTMENT>
<ORGANISATION>Erasmus University Medical Centre</ORGANISATION>
<ADDRESS_1>PO Box 1738</ADDRESS_1>
<ADDRESS_2/>
<CITY>3000 DR Rotterdam</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<PHONE_1>+31 10 7044109</PHONE_1>
<PHONE_2/>
<FAX_1>+31 10 7040003</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="12672" ROLE="AUTHOR">
<PREFIX>Ms</PREFIX>
<FIRST_NAME>Sita</FIRST_NAME>
<MIDDLE_INITIALS>MA</MIDDLE_INITIALS>
<LAST_NAME>Bierma-Zeinstra</LAST_NAME>
<SUFFIX>PhD</SUFFIX>
<POSITION>Associate Professor</POSITION>
<EMAIL_1>s.bierma-zeinstra@erasmusmc.nl</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of General Practice</DEPARTMENT>
<ORGANISATION>Erasmus Medical Centre University</ORGANISATION>
<ADDRESS_1>Room F320</ADDRESS_1>
<ADDRESS_2>PO Box 2040</ADDRESS_2>
<CITY>Rotterdam</CITY>
<ZIP>3000 CA</ZIP>
<REGION/>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<PHONE_1>+31 10 4087633</PHONE_1>
<PHONE_2/>
<FAX_1>+31 10 4089491</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="14901" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Maarten</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Boers</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>m.boers@vumc.nl</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Clinical Epidemiology</DEPARTMENT>
<ORGANISATION>Free University Hosptial</ORGANISATION>
<ADDRESS_1>VE-9 oost</ADDRESS_1>
<ADDRESS_2>PO Box 7057</ADDRESS_2>
<CITY>1007 MB Amsterdam</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<PHONE_1>31-20-444-4474</PHONE_1>
<PHONE_2/>
<FAX_1>31-20-444-4475</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="13813" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Jefferson</FIRST_NAME>
<MIDDLE_INITIALS>Rosa</MIDDLE_INITIALS>
<LAST_NAME>Cardoso</LAST_NAME>
<SUFFIX>PT, PhD.</SUFFIX>
<POSITION/>
<EMAIL_1>jeffcar@uel.br</EMAIL_1>
<EMAIL_2>jeffcar@hotmail.com</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Physical Therapy Department</DEPARTMENT>
<ORGANISATION>Universidade Estadual de Londrina</ORGANISATION>
<ADDRESS_1>Av. Robert Koch 60</ADDRESS_1>
<ADDRESS_2/>
<CITY>Londrina</CITY>
<ZIP>86038-350</ZIP>
<REGION>Paraná</REGION>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<PHONE_1>55 43 3371 2649</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="011ACB9482E26AA20178986BDE77AFDD" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Johan</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Lambeck</LAST_NAME>
<SUFFIX/>
<POSITION>B Physiotherapist</POSITION>
<EMAIL_1>lambeck.hydro@freeler.nl</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE>0031 6 109 47 125</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>Faculty of Kinesiology and rehabilitation sciences Katholieke</DEPARTMENT>
<ORGANISATION>Universiteit Leuven Tervuursevest</ORGANISATION>
<ADDRESS_1>101</ADDRESS_1>
<ADDRESS_2/>
<CITY>Leuven</CITY>
<ZIP>3001</ZIP>
<REGION/>
<COUNTRY CODE="BE">Belgium</COUNTRY>
<PHONE_1>0031 6 109 47 125</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="5522" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Rob</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>de Bie</LAST_NAME>
<SUFFIX/>
<POSITION>Professor of Physiotherapy Research</POSITION>
<EMAIL_1>ra.deBie@epid.unimaas.nl</EMAIL_1>
<EMAIL_2>ra.debie@epid.unimaas.nl</EMAIL_2>
<URL>http://www.cebp.nl</URL>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Epidemiology</DEPARTMENT>
<ORGANISATION>Maastricht University</ORGANISATION>
<ADDRESS_1>P.O. Box 616</ADDRESS_1>
<ADDRESS_2/>
<CITY>Maastricht</CITY>
<ZIP>6200 MD</ZIP>
<REGION/>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<PHONE_1>31 43 388 2362</PHONE_1>
<PHONE_2>31 43 3882394</PHONE_2>
<FAX_1>31 43 3884128</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="0666114F82E26AA2010AB3F298C149F7" ROLE="AUTHOR">
<PREFIX>A/Prof</PREFIX>
<FIRST_NAME>Henrica</FIRST_NAME>
<MIDDLE_INITIALS>CW</MIDDLE_INITIALS>
<LAST_NAME>de Vet</LAST_NAME>
<SUFFIX>PhD</SUFFIX>
<POSITION>Professor in Clinimetrics, Programme Director Musculoskeletal Disorders</POSITION>
<EMAIL_1>hcw.devet@vumc.nl</EMAIL_1>
<EMAIL_2>HCW.de_Vet.emgo@med.vu.nl</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>EMGO Institute</DEPARTMENT>
<ORGANISATION>Vrije Universiteit Medical Center</ORGANISATION>
<ADDRESS_1>van der Boechhorstraat 7</ADDRESS_1>
<ADDRESS_2/>
<CITY>Amsterdam</CITY>
<ZIP>1081 BT</ZIP>
<REGION/>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<PHONE_1>+ 31 20 4448176</PHONE_1>
<PHONE_2>+ 31 20 4448180</PHONE_2>
<FAX_1>+ 31 20 4446775</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2008-05-21 15:41:50 -0400" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="20" MONTH="8" YEAR="2007"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="31" MONTH="10" YEAR="2006"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="30" MONTH="7" YEAR="2008"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="" YEAR=""/>
<REVIEW_PUBLISHED ISSUE="4" YEAR="2007"/>
<LAST_CITATION_ISSUE ISSUE="4" YEAR="2007"/>
</DATES>
<WHATS_NEW MODIFIED="2008-05-21 15:02:24 -0400" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2008-05-21 10:36:10 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="21" MONTH="5" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format. C009-R</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2008-05-21 15:41:18 -0400" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2008-05-21 15:41:07 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="20" MONTH="8" YEAR="2007"/>
<DESCRIPTION>
<P>Substantive amendment. See published notes for details on this update.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Erasmus MC, Rotterdam</NAME>
<COUNTRY CODE="NL">Netherlands</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2008-06-10 20:55:55 -0400" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2008-06-10 20:55:55 -0400" MODIFIED_BY="[Empty name]">
<TITLE>Balneotherapy or spa-therapy for Osteoarthritis</TITLE>
<SUMMARY_BODY MODIFIED="2008-06-10 20:55:55 -0400" MODIFIED_BY="[Empty name]">
<P>This summary of a Cochrane review presents what we know from research about the effect of Balneotherapy (mineral baths) for Osteoarthritis (OA). The review shows that in people with OA: 
</P>
<P>- Spending time in a mineral bath compared to no treatment may improve pain and quality of life.<BR/>- Spending time in both a sulfur bath and a dead sea bath compared to no treatment may improve pain one month after treatment.<BR/>- Spending time in a sulfur bath or a Dead Sea bath compared to no treatment may not lead to any difference in pain.</P>
<P>There is not enough data to tell if spending time in mineral baths has any effect on a person's physical function or their quality of life.<BR/>How people felt overall and any side effects were not measured in these studies.</P>
<P>
<B>What is osteoarthritis (OA) and what is balneotherapy?</B>
<BR/>Osteoarthritis is a disease of the joints. When joints lose cartilage, the bone in your joints tries to repair the damage. Instead of making things better, however, the bone grows abnormally and makes things worse. For example, the bone can become misshapen and make the joint painful and unstable.<BR/>Doctors used to think that osteoarthritis was caused by wear and tear on the cartilage. However, it's now thought that osteoarthritis is a disease of the whole joint. OA is one of the most common forms of arthritis and affects men and women equally. For many people OA is one of the main causes of long-term disability.</P>
<P>Balneotherapy or spa-therapy is an ancient and popular therapy. It involves spending time in an indoor pool filled with mineral water at temperature of between 31 to 34 degrees Celsius (88 to 93 degrees Farenheit). Different types of mineral water may be used in this therapy.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT>
<ABS_BACKGROUND>
<P>Balneotherapy (or spa therapy, mineral baths) for patients with arthritis is one of the oldest forms of therapy. One of the aims of balneotherapy is to soothe the pain and as a consequence to relieve patients' suffering and make them feel well. In this update we included one extra study.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To assess the effectiveness of balneotherapy for patients with osteoarthritis (OA).</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY>
<P>We searched the following databases up to October 2006: EMBASE, PubMed, the Cochrane 'Rehabilitation and Related Therapies' Field database, PEDro, CENTRAL (Issue 3, 2006) and performed reference checking and communicated with authors to retrieve eligible studies. </P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>Randomised controlled trials (RCT) comparing balneotherapy with any intervention or no intervention. At least 90% of the patient population had to be diagnosed with OA. </P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>Two authors independently assessed quality and extracted data. Disagreements were solved by consensus. In the event of clinical heterogeneity or lack of data we refrained from statistical pooling.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS>
<P>Seven trials (498 patients) were included in this review. Two studies compared spa-treatment with no treatment. One study evaluated baths as an add-on treatment to home exercises and another compared thermal water from Cserkeszölö with tap water (placebo). Three studies evaluated sulphur or Dead Sea baths with no treatment or mineral baths with tap water baths or no treatment. Only one of the trials performed an intention-to-treat analysis and two studies provided data to perform an intention-to-treat analysis ourselves. A 'quality of life' outcome was reported by one trial.</P>
<P>We found: <BR/>
</P>
<P>silver level evidence concerning the beneficial effects on pain, quality of life and analgesic intake of mineral baths compared to no treatment (SMD between 1.82 and 0.34). <BR/>a statistically significant difference in pain and function of Dead Sea + sulphur versus no treatment, only at end of treatment (WMD 5.7, 95%CI 3.3 to 8.1), but not at 3 month follow-up (WMD 2.6, 95%CI -1.1 to 6.3). <BR/>no statistically significant differences in pain or function at one or three months of Dead Sea baths versus no treatment (WMD 0.5, 95%CI -0.6 to 1.6) or at one or three months of sulphur baths versus no treatment (WMD 0.4, 95%CI -0.9 to 1.7). </P>
<P>
<BR/>Adverse events were not measured in the included trials.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P>We found silver level evidence (www.cochranemsk.org) concerning the beneficial effects of mineral baths compared to no treatment. Of all other balneological treatments no clear effects were found. However, the scientific evidence is weak because of the poor methodological quality and the absence of an adequate statistical analysis and data presentation. Therefore, the noted "positive findings" should be viewed with caution. </P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-05-21 15:48:50 -0400" MODIFIED_BY="[Empty name]">
<BACKGROUND>
<P>Osteoarthritis (OA) is a degenerative joint disease marked by degeneration of the articular cartilage, hypertrophy of bone at the margins, and changes in the synovial membrane (<LINK REF="REF-Solomon-1997" TYPE="REFERENCE">Solomon 1997</LINK>). OA is one of the most common forms of arthritis and affects men and women equally. For many adults OA is one of the most important causes of long-term disability (<LINK REF="REF-Peyron-1993" TYPE="REFERENCE">Peyron 1993</LINK>; <LINK REF="REF-Solomon-1997" TYPE="REFERENCE">Solomon 1997</LINK>). Osteoarthritis can affect any joint but usually affects the hips, knees, hands and spine. The knee appears to be the joint most prone to the development of OA (<LINK REF="REF-Brosseau-2002" TYPE="REFERENCE">Brosseau 2002</LINK>). This may be because it is a major weight bearing joint, and prone to effects of obesity, trauma, as well as some metabolic diseases (<LINK REF="REF-Fife-1991" TYPE="REFERENCE">Fife 1991</LINK>). Pain in the knee is exacerbated by movement or weight bearing, and stiffness, edema and deformity, reduced function, such as walking is common complaints in patients with OA of the knee.</P>
<P>There is no cure for OA at present, so treatment often focuses on the management of symptoms such as pain, stiffness and mobility. Treatment options include pharmacological interventions, physiotherapy treatments or balneotherapy.</P>
<P>The term balneotherapy comes from the Latin balneum (bath). The term is classically used for bathing in thermal or mineral waters, and has been distinguished from hydrotherapy, but since the beginning of this century both terms were accepted for all forms of treatment with water (<LINK REF="REF-Johnson-1990" TYPE="REFERENCE">Johnson 1990</LINK>). We will use the term balneotherapy since bathing for therapeutic use very often happens in spas. The water (thermal water, sea water or tap water) is generally used at a temperature of around 34 degrees Celsius (<LINK REF="REF-Simon-1981" TYPE="REFERENCE">Simon 1981</LINK>). The hydrostatic force (Archimedes' principle) brings about a relative pain relief by reducing loading (<LINK REF="REF-Simon-1981" TYPE="REFERENCE">Simon 1981</LINK>); the water reduces gravity on painful and rheumatic joints.</P>
<P>Bathing in water (balneotherapy or spa therapy) has been frequently used in classical medicine as a cure for diseases. Water from mineral and thermal springs was particularly valued (<LINK REF="REF-Jackson-1990" TYPE="REFERENCE">Jackson 1990</LINK>). In Homeric times, baths were applied primarily to cleanse and refresh. At the time of Hippocrates, bathing was regarded as more than a simple hygienic measure, it was considered beneficial to cure most illnesses (<LINK REF="REF-v-Tubbergen-2002" TYPE="REFERENCE">v Tubbergen 2002</LINK>). The Romans used water for the therapeutic treatment of orthopaedic conditions, but after the Roman era, spa therapy fell into disuse. In the sixteenth century baths were rediscovered. Since then, spa therapy has been practiced continuously in the management of musculoskeletal conditions (<LINK REF="REF-Brosseau-2002" TYPE="REFERENCE">Brosseau 2002</LINK>; <LINK REF="REF-v-Tubbergen-2002" TYPE="REFERENCE">v Tubbergen 2002</LINK>). </P>
<P>Spa therapy is a very popular form of treatment for all forms of arthritis in many European countries and in Israel (<LINK REF="REF-Fam-1991" TYPE="REFERENCE">Fam 1991</LINK>; <LINK REF="REF-Nicholas-1994" TYPE="REFERENCE">Nicholas 1994</LINK>). In most West European countries spa therapy often takes place at centres with thermal baths or seawater baths (<LINK REF="REF-Cosh-1982" TYPE="REFERENCE">Cosh 1982</LINK>). In Israel, the main health resort area is located along the western shore of the Dead Sea. The unique environmental conditions in this area are considered beneficial to patients suffering from rheumatic diseases (<LINK REF="REF-Sukenik-1994a" TYPE="REFERENCE">Sukenik 1994a</LINK>). </P>
<P>The aim of balneotherapy is to improve the range of joint motion, cause muscle strengthening, relieve muscle spasm, maintain or improve functional mobility, soothe pain and as a consequence to relieve patients' suffering and let them feel well (<LINK REF="REF-Fam-1991" TYPE="REFERENCE">Fam 1991</LINK>; <LINK REF="REF-Jagger-1984" TYPE="REFERENCE">Jagger 1984</LINK>; <LINK REF="REF-Sukenik-1994a" TYPE="REFERENCE">Sukenik 1994a</LINK>). Balneotherapy is most often prescribed for patients with any form of arthritis. In 1994, the Italian Ministry of Health granted a project (the Naiade Italian project) to evaluate the role of spa medicine in various diseases, including the evaluation of spa therapy in OA (<LINK REF="REF-Fioravanti-2003" TYPE="REFERENCE">Fioravanti 2003</LINK>). This involved a large cohort study evaluating over 11,000 patients for 2 years. All patients were treated in Italian spas. This study found a reduction of additional treatments and sick leave especially in patients with OA in the spine. </P>
<P>Despite the popularity, reported scientific evidence for the effectiveness or efficacy of balneotherapy is sparse. This review evaluates the effects of balneotherapy in patients with osteoarthritis.</P>
</BACKGROUND>
<OBJECTIVES>
<P>The primary objective was to perform a systematic review on the effects of balneotherapy in patients with osteoarthritis.</P>
</OBJECTIVES>
<METHODS>
<SELECTION_CRITERIA>
<CRIT_STUDIES>
<P>Studies were eligible if they were randomised controlled trials (RCTs).</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Studies were included if at least 90% of trial participants had osteoarthritis (OA). </P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>Balneotherapy had to be the intervention under study, and had to be compared with another intervention or with no intervention. Balneotherapy is defined as: bathing in water. This water may contain minerals (added or natural).</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES>
<P>In 1996 the Osteo-Arthritis Research Society International (OARSI) developed a core set of endpoints in clinical trials concerning patients with OA, which has been updated recently in combination with OMERACT (<LINK REF="REF-Pham-2003" TYPE="REFERENCE">Pham 2003</LINK>). Main endpoints found relevant were: pain, physical function, patient global assessment, quality of life, measured using the WOMAC index, the Indices of Clinical Severity, AUSCAN index, Algofunctional Index, HAQ, and AIMS (2). At least one of these endpoints had to be among the main outcome measures. Studies were excluded when only laboratory variables were reported as outcome measures.</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS>
<P>Using the Cochrane search strategy, studies were found by screening EMBASE and PubMed database up to October 2006, the database from the Cochrane 'Rehabilitation and Related Therapies' Field up to October 2006, Cochrane Central Register of Controlled Trials (CENTRAL) (Issue 3, 2006), Pedro database up to October 2006, reference checking and personal communications with authors was carried out to retrieve eligible studies. <BR/>
<BR/>In PubMed the following subject specific search strategy was combined with all three levels of the optimal trial search strategy as defined by the Cochrane Handbook (<LINK REF="REF-Robinson-2002" TYPE="REFERENCE">Robinson 2002</LINK>): <BR/>
<BR/>#1: (arthritis OR artritis)</P>
<P>#2: (balneotherapy OR balneology OR spa therapy OR water therapy OR hydrotherapy OR thalassotherapy) </P>
<P>#1 AND #2<BR/>
<BR/>No language restrictions were applied, but studies not reported in English, Dutch, Danish, Swedish, Norwegian, German, or French are awaiting assessment (see reference list of studies awaiting assessment). First titles and abstracts of identified published articles were reviewed in order to determine the relevancy of the articles. Two reviewers (APV and JL) performed the search independently.</P>
</SEARCH_METHODS>
<DATA_COLLECTION>
<P>
<B>Methodological quality<BR/>
</B>The effectiveness of balneotherapy is presented and discussed based upon the methodological quality. Methodological quality is assessed by means of the "Delphi list" for quality assessment of RCTs (<LINK REF="REF-Verhagen-1998" TYPE="REFERENCE">Verhagen 1998</LINK>), see below. All criteria have a "yes", "no", "don't know" answer format. In this review the quality components of the studies were determined independently by two of these authors (HCWdV, RAdB, APV) followed by a consensus meeting. If disagreements persisted the third reviewer made a final decision. </P>
<P>Table 1: Methodological criteria list<BR/>1. Was a method of randomisation performed? <BR/>2. Was the treatment allocation concealed?<BR/>3. Were the groups similar at baseline regarding the most important prognostic indicators?<BR/>4. Were eligibility criteria specified? <BR/>5. Was the outcome assessor blinded? <BR/>6. Was the care provider blinded?<BR/>7. Was the patient blinded?<BR/>8. Were point estimates and measures of variability presented for the primary outcome measures?<BR/>9. Did the analysis include an intention-to-treat analysis?</P>
<P>
<B>Data extraction</B>
<BR/>Two reviewers (JC, APV) independently extracted data regarding the interventions, type of outcome measures, follow-up, loss to follow-up, and outcomes, using a standardized form. </P>
<P>
<B>Analysis</B>
<BR/>High quality is defined as: presenting a concealed randomisation procedure and blinding of the outcome assessor. We calculated an inter-observer reliability of the overall quality assessment using IntraClass Correlation Coefficients (ICC). ICC &gt; 0.7 are considered as good agreement, between 0.5 and 0.7 as moderate, and &lt; 0.5 as poor agreement. </P>
<P>
<I>Quantitative analysis<BR/>
</I>The various outcome measures are presented separately (see Graphs). For dichotomous data results are expressed, when possible, as relative risks (RR) with corresponding 95 percent confidence intervals, and as weighted mean differences with 95 percent confidence intervals for continuous data (<LINK REF="REF-Lau-1997" TYPE="REFERENCE">Lau 1997</LINK>). RevMan Analyses was used to analyse the data. Pooling was not implemented, as studies were considered clinically heterogeneous concerning study population, intervention and outcome measures. </P>
<P>
<I>Qualitative analysis<BR/>
</I>In case of clinical heterogeneity, or if data were lacking, we analysed the results using the CMSG system. Clinical relevance tables were made according to the CMSG guidelines to evaluate the strength of the evidence.</P>
<P>
<I>Grading of the evidence</I>
</P>
<P>We used the grading system described in the 2004 book Evidence-based Rheumatology (<LINK REF="REF-Tugwell-2004" TYPE="REFERENCE">Tugwell 2004</LINK>) and recommended by the Musculoskeletal Group:<BR/>
</P>
<UL>
<LI>Platinum: A published systematic review that has at least two individual controlled trials each satisfying the following : </LI>
<LI>Sample sizes of at least 50 per group - if these do not find a statistically significant difference, they are adequately powered for a 20% relative difference in the relevant outcome. </LI>
<LI>Blinding of patients and assessors for outcomes. </LI>
<LI>Handling of withdrawals &gt;80% follow up (imputations based on methods such as Last Observation Carried Forward (LOCF) are acceptable). </LI>
<LI>Concealment of treatment allocation. </LI>
</UL>
<P>
<BR/>Gold: At least one randomised clinical trial meeting all of the following criteria for the major outcome(s) as reported: <BR/>
</P>
<UL>
<LI>Sample sizes of at least 50 per group - if these do not find a statistically significant difference, they are adequately powered for a 20% relative difference in the relevant outcome. </LI>
<LI>Blinding of patients and assessors for outcomes. </LI>
<LI>Handling of withdrawals &gt; 80% follow up (imputations based on methods such as LOCF are acceptable). </LI>
<LI>Concealment of treatment allocation. </LI>
</UL>
<P>
<BR/>Silver: A randomised trial that does not meet the above criteria. Silver ranking would also include evidence from at least one study of non-randomised cohorts that did and did not receive the therapy, or evidence from at least one high quality case-control study. A randomised trial with a 'head-to-head' comparison of agents would be considered silver level ranking unless a reference were provided to a comparison of one of the agents to placebo showing at least a 20% relative difference. </P>
<P>Bronze: The bronze ranking is given to evidence if at least one high quality case series without controls (including simple before/after studies in which patients act as their own control) or if the conclusion is derived from expert opinion based on clinical experience without reference to any of the foregoing (for example, argument from physiology, bench research or first principles). </P>
<P>
<I>Clinical relevance tables </I>
<BR/>Clinical relevance tables were compiled under 'Additional tables' to improve the readability of the review. Absolute benefit was calculated as the improvement in the intervention group minus the improvement in the control group, in the original units. Relative difference in the change from baseline was calculated as the absolute benefit divided by the baseline mean of the control group. NNT was calculated using the Wells calculator software available at the CMSG editorial office. The minimal clinically important difference (MCID) for each outcome was determined to be 15% for input into the calculator.</P>
<P>
<I>Pre-planned analyses were: </I>
<BR/>a) Trials comparing balneotherapy with no treatment or waiting list controls.<BR/>b) Trials comparing different types of balneotherapy<BR/>c) Trials comparing balneotherapy with other treatment(s) (e.g., exercises, oral medication) </P>
</DATA_COLLECTION>
</METHODS>
<RESULTS>
<STUDY_DESCRIPTION>
<P>
<B>Study selection<BR/>
</B>In total, 70 references were selected based on title and abstract. Of these, 63 studies were excluded because: a) awaiting assessment based on language (n=22); b) the design was not an RCT (n=18); c) did not concern patients with osteoarthritis (n=11), d) no balneotherapy was given (n=8) and e) lack of relevant outcome measure (n=4). Seven trials were found which met the eligibility criteria (<LINK REF="STD-Allard-1998" TYPE="STUDY">Allard 1998</LINK>; <LINK REF="STD-Green-1993" TYPE="STUDY">Green 1993</LINK>; <LINK REF="STD-Kov_x00e1_cs-2002" TYPE="STUDY">Kovács 2002</LINK>; <LINK REF="STD-Nguyen-1997" TYPE="STUDY">Nguyen 1997</LINK>; <LINK REF="STD-Sukenik-1999" TYPE="STUDY">Sukenik 1999</LINK>; <LINK REF="STD-Tishler-2004" TYPE="STUDY">Tishler 2004</LINK>; <LINK REF="STD-Wigler-1995" TYPE="STUDY">Wigler 1995</LINK>). Finally, one extra study could be included in this updated review.</P>
<P>
<B>Patients</B>
<BR/>A total of 498 patients were enrolled, and the number of patients in the intervention groups varied from 10 to 97 (see Table of Included Studies). When mentioned, the percentage of males was between 0-26% and the mean age varied between 54.6 and 68 years. </P>
<P>
<B>Interventions<BR/>
</B>In all but one study (<LINK REF="STD-Green-1993" TYPE="STUDY">Green 1993</LINK>) the intervention included mineral baths, and in one study the intervention was in combination with mudpacks (<LINK REF="STD-Wigler-1995" TYPE="STUDY">Wigler 1995</LINK>). Four studies included a control group receiving no treatment (<LINK REF="STD-Allard-1998" TYPE="STUDY">Allard 1998</LINK>; <LINK REF="STD-Nguyen-1997" TYPE="STUDY">Nguyen 1997</LINK>; <LINK REF="STD-Sukenik-1999" TYPE="STUDY">Sukenik 1999</LINK>; <LINK REF="STD-Tishler-2004" TYPE="STUDY">Tishler 2004</LINK>), and in two studies a control group received tap water (<LINK REF="STD-Kov_x00e1_cs-2002" TYPE="STUDY">Kovács 2002</LINK>; <LINK REF="STD-Wigler-1995" TYPE="STUDY">Wigler 1995</LINK>). In one study, bathing was evaluated as an add-on treatment to home exercises (<LINK REF="STD-Green-1993" TYPE="STUDY">Green 1993</LINK>). In this study, no information was provided about the water or any instruction about the bathing procedure (it is called hydrotherapy, but no information about exercises in water is provided), and no data on pain and function were presented. In all trials, patients continued their medication during balneotherapy. In one study, several mineral baths (Sulphur baths and Dead Sea baths) were compared with each other (<LINK REF="STD-Sukenik-1999" TYPE="STUDY">Sukenik 1999</LINK>).</P>
<P>
<B>Outcome measures</B>
<BR/>All studies used a number of outcome measures including pain and function and in one study (<LINK REF="STD-Nguyen-1997" TYPE="STUDY">Nguyen 1997</LINK>) a 'quality of life' instrument (AIMS) was used. Three studies (<LINK REF="STD-Green-1993" TYPE="STUDY">Green 1993</LINK>; <LINK REF="STD-Nguyen-1997" TYPE="STUDY">Nguyen 1997</LINK>; <LINK REF="STD-Wigler-1995" TYPE="STUDY">Wigler 1995</LINK>), mentioned a follow-up period of 18, 20 or 24 weeks; all other studies measured outcomes at start and end of treatment.</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY>
<P>The results of the assessment of methodological quality are shown in <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK> and the notes section of the Table of Included Studies. Concerning quality assessment the ICC between two reviewers appeared to be high: 0.76 (95% CI: 0.40 - 0.95).</P>
<P>No studies mentioned a concealed randomisation procedure, and no study was therefore considered of high quality. In most studies a considerable amount of information concerning study design was lacking or unclear. <BR/>Blinding of the outcome assessor (observer) is mentioned in four studies (<LINK REF="STD-Green-1993" TYPE="STUDY">Green 1993</LINK>; <LINK REF="STD-Kov_x00e1_cs-2002" TYPE="STUDY">Kovács 2002</LINK>; <LINK REF="STD-Sukenik-1999" TYPE="STUDY">Sukenik 1999</LINK>; <LINK REF="STD-Wigler-1995" TYPE="STUDY">Wigler 1995</LINK>) and blinding of the patient twice (<LINK REF="STD-Kov_x00e1_cs-2002" TYPE="STUDY">Kovács 2002</LINK>; <LINK REF="STD-Wigler-1995" TYPE="STUDY">Wigler 1995</LINK>), but success of blinding was never evaluated. In one study (<LINK REF="STD-Tishler-2004" TYPE="STUDY">Tishler 2004</LINK>) the authors mention that randomisation was blinded to the patient, but patients had to sign informed consent and they mention the withdrawal of 14 patients after reading the protocol and two patients after being randomised to the control group. Therefore we did not consider this study blinded for the patient (<LINK REF="STD-Tishler-2004" TYPE="STUDY">Tishler 2004</LINK>).</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2008-05-21 15:48:50 -0400" MODIFIED_BY="[Empty name]">
<P>All studies included over 90% patients with OA. One study included participants with radiographic hip OA (<LINK REF="STD-Green-1993" TYPE="STUDY">Green 1993</LINK>); two studies, participants with radiographic knee OA (<LINK REF="STD-Wigler-1995" TYPE="STUDY">Wigler 1995</LINK>); one study, participants with clinically and radiographic knee OA (<LINK REF="STD-Kov_x00e1_cs-2002" TYPE="STUDY">Kovács 2002</LINK>); one study, participants with clinical knee OA (<LINK REF="STD-Tishler-2004" TYPE="STUDY">Tishler 2004</LINK>) and in one study participants with knee, hip or lumbar OA (<LINK REF="STD-Nguyen-1997" TYPE="STUDY">Nguyen 1997</LINK>). Five studies (<LINK REF="STD-Allard-1998" TYPE="STUDY">Allard 1998</LINK>; <LINK REF="STD-Green-1993" TYPE="STUDY">Green 1993</LINK>; <LINK REF="STD-Kov_x00e1_cs-2002" TYPE="STUDY">Kovács 2002</LINK>; <LINK REF="STD-Nguyen-1997" TYPE="STUDY">Nguyen 1997</LINK>; <LINK REF="STD-Tishler-2004" TYPE="STUDY">Tishler 2004</LINK>) had two treatment groups; <LINK REF="STD-Wigler-1995" TYPE="STUDY">Wigler 1995</LINK> compared three treatment groups and <LINK REF="STD-Sukenik-1999" TYPE="STUDY">Sukenik 1999</LINK> compared four. Four studies provided enough data to be able to perform a between group analysis in this review (<LINK REF="STD-Kov_x00e1_cs-2002" TYPE="STUDY">Kovács 2002</LINK>; <LINK REF="STD-Nguyen-1997" TYPE="STUDY">Nguyen 1997</LINK>; <LINK REF="STD-Sukenik-1999" TYPE="STUDY">Sukenik 1999</LINK>; <LINK REF="STD-Tishler-2004" TYPE="STUDY">Tishler 2004</LINK>). All studies used different interventions or comparison treatments, and a wide variety of outcome measures; therefore, study populations, interventions and outcome measures were considered very heterogeneous. Only one study assessed side effects (<LINK REF="STD-Wigler-1995" TYPE="STUDY">Wigler 1995</LINK>), but none were found.</P>
<P>
<B>Trials comparing balneotherapy with placebo or no treatment/waiting list controls</B>
<BR/>Four studies included a control group receiving no treatment (<LINK REF="STD-Allard-1998" TYPE="STUDY">Allard 1998</LINK>; <LINK REF="STD-Nguyen-1997" TYPE="STUDY">Nguyen 1997</LINK>; <LINK REF="STD-Sukenik-1999" TYPE="STUDY">Sukenik 1999</LINK>; <LINK REF="STD-Tishler-2004" TYPE="STUDY">Tishler 2004</LINK>). In all studies the patients were not, or could not be, blinded for the treatment. Three studies provided data showing beneficial effects on pain, quality of life and analgesic intake of balneotherapy (<LINK REF="STD-Nguyen-1997" TYPE="STUDY">Nguyen 1997</LINK>; <LINK REF="STD-Sukenik-1999" TYPE="STUDY">Sukenik 1999</LINK>; <LINK REF="STD-Tishler-2004" TYPE="STUDY">Tishler 2004</LINK>) varying from 6.6% difference between groups to 56.6% difference. At the end of treatment, data showed no evidence of statistically significant differences between Dead Sea baths and no treatment (<LINK REF="STD-Sukenik-1999" TYPE="STUDY">Sukenik 1999</LINK>). Also, sulphur baths alone showed no evidence of statistically significant differences when compared to no treatment, but the overall power of the study is low (<LINK REF="STD-Sukenik-1999" TYPE="STUDY">Sukenik 1999</LINK>). When Dead Sea Baths were combined with sulphur baths beneficial effects were shown on pain and function only at end of treatment or 1-month follow-up, but not at 3 months (<LINK REF="STD-Sukenik-1999" TYPE="STUDY">Sukenik 1999</LINK>). The results of <LINK REF="STD-Nguyen-1997" TYPE="STUDY">Nguyen 1997</LINK> and <LINK REF="STD-Tishler-2004" TYPE="STUDY">Tishler 2004</LINK> on pain (18.5% and 56.6% relative difference, respectively) reached statistical significance, which was more profound on the short term (end of treatment).</P>
<P>One study evaluated the additional effectiveness of balneotherapy on home exercises (<LINK REF="STD-Green-1993" TYPE="STUDY">Green 1993</LINK>). No information on the intervention procedure was provided, nor data on outcome measures such as pain or function were provided, so no conclusion about its effectiveness can be drawn. The authors mention no additional value of bathing.</P>
<P>
<B>Trials comparing different types of balneotherapy<BR/>
</B>In two studies mineral baths (in one study combined with two different mud packs) were compared to tap water baths lacking the special element of the specific intervention of each study (<LINK REF="STD-Kov_x00e1_cs-2002" TYPE="STUDY">Kovács 2002</LINK>; <LINK REF="STD-Wigler-1995" TYPE="STUDY">Wigler 1995</LINK>). The study of <LINK REF="STD-Wigler-1995" TYPE="STUDY">Wigler 1995</LINK> did not provide data, only graphs were presented showing rather similar results on pain and function in all three groups. No data were provided in the study of <LINK REF="STD-Kov_x00e1_cs-2002" TYPE="STUDY">Kovács 2002</LINK>, but the authors mentioned more improvement in the mineral bath groups when compared to tap water on pain, range of motion, function and perceived recovery.</P>
<P>In one study, Dead Sea salt baths were compared with Sulphur baths (<LINK REF="STD-Sukenik-1999" TYPE="STUDY">Sukenik 1999</LINK>). No significant differences were found between Dead Sea salt baths and Sulphur baths in favour of one of the baths. The study was of low quality and had low power.</P>
<P>
<B>Trials comparing balneotherapy with other treatments (e.g., exercises, oral medication)<BR/>
</B>No studies were found which compared balneotherapy with another form of treatment.</P>
<P>A clinical relevance table for pain at follow up can be found in Additional <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION>
<P>We conclude that mineral baths seem to be more beneficial when compared to no treatment on pain, quality of life and analgesics intake. Dead sea baths alone and sulphur baths alone showed no evidence of effect. Furthermore, we conclude that one type of mineral baths is probably not more effective compared to another type of mineral baths.</P>
<P>This review evaluated the effectiveness of balneotherapy in patients with osteoarthritis (OA). Unfortunately, most studies were of low power and had methodological flaws. When information concerning trial design, especially on strategies to avoid bias, is lacking possible bias in the trial cannot be excluded. Therefore, a robust analysis of the effectiveness of balneotherapy cannot be presented. We found only silver level evidence concerning the positive effect of balneotherapy (mineral baths) when compared to no treatment on pain, quality of life and analgesic intake. Our conclusions confirm the conclusions of <LINK REF="REF-Brosseau-2002" TYPE="REFERENCE">Brosseau 2002</LINK>, although they more clearly focus on clinically relevant differences. </P>
<P>Our review might very well suffer from selection bias based on language. Several studies were found presented in Hebrew, Japanese or in one of the Easter European languages. Often the English abstract was not able to provide information about the design of the study. These studies are all awaiting assessment.</P>
<P>We used the 'Delphi list' for quality assessment (<LINK REF="REF-Verhagen-1998" TYPE="REFERENCE">Verhagen 1998</LINK>). Overall this criteria list can be regarded as a reliable and valid instrument (<LINK REF="REF-Verhagen-2001" TYPE="REFERENCE">Verhagen 2001</LINK>). Nevertheless, misclassification is always a possibility. The quality assessment in this review appeared to be reliable. Based on the quality components 'concealed randomisation' and blinding the outcome assessor, no study appeared to be of high quality. </P>
<P>Osteoarthritis is a chronic and disabling disease and has great impact on quality of life. When evaluating balneotherapy the outcome measures used and the follow-up period chosen should be adequate. The main aim of balneotherapy is to maintain or improve functional mobility, soothe pain and to let the patients feel well. 'Quality of life' was used as an outcome measure on only one of seven studies. This is surprising because one of the aims of balneotherapy, or therapy for chronic patients in general, is to improve health related 'quality of life'. In daily life patients are trying to deal with pain by using coping strategies. Pain was reported as an outcome measure in the methods sections of most of the studies, but data concerning the pain were only reported in three studies concerning 345 participants (<LINK REF="STD-Nguyen-1997" TYPE="STUDY">Nguyen 1997</LINK>; <LINK REF="STD-Sukenik-1999" TYPE="STUDY">Sukenik 1999</LINK>; <LINK REF="STD-Tishler-2004" TYPE="STUDY">Tishler 2004</LINK>). <BR/>Also the follow-up period seems to be rather short, and was lacking in three studies (outcomes were only measured at the end of treatment). </P>
<P>We noted heterogeneity of the intervention 'balneotherapy'. In one study, mineral baths (38 degrees Celsius, daily for 20 minutes) plus mud packs (for 20 minutes) was evaluated. In another study, Dead Sea baths (daily for 20-30 minutes), sulphur baths (daily for 20 minutes), or a combination of Dead Sea and sulphur baths were evaluated. Finally, in three studies 'spa-therapy' was evaluated (see Table of Included Studies). This makes it difficult to determine what the most effective form of balneotherapy is. The 'spa environment' is an important factor in treatment results (<LINK REF="REF-Balint-1993" TYPE="REFERENCE">Balint 1993</LINK>; <LINK REF="REF-Sukenik-1994a" TYPE="REFERENCE">Sukenik 1994a</LINK>). Many factors may contribute positively to the reported effects (<LINK REF="REF-Fam-1991" TYPE="REFERENCE">Fam 1991</LINK>), such as change of environment, the 'spa-scenery', the absence of (house) work duties, physical and mental relaxation, the non-competitive atmosphere with similarly suffering companions, physical therapy, etc. As such, spa benefits could perhaps be attributed also to the effects of factors unrelated to the "water" therapy <I>per se</I>. These spa benefits are especially important in studies evaluating the effects of balneotherapy compared to no treatment or another treatment.</P>
<P>Our conclusion of this review is that there appeared to be silver level evidence in favour of balneotherapy when compared to no treatment and that a firm conclusion on the effectiveness of several forms of balneotherapy in patients with OA cannot be drawn. These results are comparable with the results of another Cochrane review on balneotherapy in patients with rheumatoid arthritis. </P>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE>
<P>Most studies presented positive findings, but we found silver level evidence concerning the beneficial effects of mineral baths compared to no treatment. In most studies the scientific evidence is insufficient because of the poor methodological quality, the absence of an adequate statistical analysis, and for the patient, the absence of essential outcome measures (pain, quality of life). Because of these methodological flaws a firm answer about the effectiveness of balneotherapy cannot be provided based on the included studies.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P>1. Large, high quality research is needed, focusing on appropriate allocation concealment, blinding and an adequate data presentation and analysis. The design and reporting of future trials should be conforming the CONSORT-statement. <BR/>2. New research should use outcome measures relevant to the patients, and adequate and responsive to the treatment under study. Follow-up should be of sufficient length to assess long-term effects, all according to the OARSI-guideline (<LINK REF="REF-Bellamy-1999" TYPE="REFERENCE">Bellamy 1999</LINK>; <LINK REF="REF-Pham-2003" TYPE="REFERENCE">Pham 2003</LINK>). <BR/>3. New research should provide full data on outcome measures, including the mean and standard deviation or 95% confidence interval, and making comparisons between intervention groups.<BR/>4. Future research should examine the effect of balneotherapy not only in pragmatic trials comparing various interventions with each other, but also in more explanatory trials comparing the intervention with a no treatment control group. When possible, the beneficial effect of the 'spa-environment' should be accounted for in the design of the trial.</P>
<P>We conclude that performing randomised studies with high methodological quality concerning the effectiveness of balneotherapy is both possible and necessary to provide strong evidence on the effects of balneotherapy. Flaws found in the reviewed studies could and should be avoided in future trials.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>We are indebted to the authors of the studies included in this review for their support in retrieving and clarifying original research. Furthermore, we would like to thank the consumers association of water therapy. Their questions formed the basis of this review.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS>
<P>Arianne Verhagen (APV) and Henrica de Vet (HCWdV) initiated the review and APV wrote the first draft of the review. APV developed the search strategy and APV and Sita Bierma (SMABZ) performed study selection, analysis and writing the review. For the most recent update also Johan Lambeck (JL) performed the study selection together with APV. Rob de Bie (RAdB), APV and HCWdV performed the quality assessment, Jefferson Cardoso (JC) and APV performed data-extraction<BR/>SMABZ, RAdB, JC. Maarten Boers (MB) and HCWdV all critically reviewed successive drafts of the review. APV is the guarantor of the review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES MODIFIED="2008-05-21 10:36:52 -0400" MODIFIED_BY="[Empty name]">
<P>In this update (August 2007) we found one extra study (n=68 patients). Combined with the existing studies we continue to conclude that mineral baths are probably effective when compared to no treatment. Because of the lack of high quality studies the strength of the evidence however is still limited.</P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES>
<STUDIES>
<INCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Allard-1998" NAME="Allard 1998" YEAR="1998">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Allard P, Deligne J, van Bockstael V, Duquesnoy B</AU>
<TI>Is spa therapy cost-effective in rheumatoid disorders?</TI>
<SO>Revue du Rhumatisme [Engl. Ed]</SO>
<YR>1998</YR>
<VL>65</VL>
<NO>3</NO>
<PG>173-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Green-1993" NAME="Green 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Green J, McKenna F, Redfern EJ, Chamberlain MA</AU>
<TI>Home exercises are as effective as outpatient hydrotherapy for osteoarthritis of the hip</TI>
<SO>British Journal of Rheumatology</SO>
<YR>1993</YR>
<VL>32</VL>
<PG>812-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kov_x00e1_cs-2002" NAME="Kovács 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kovács I, Bender T</AU>
<TI>The therapeutic effects of Cserkeszölö thermal water in osteoarthritis of the knee: a double blind, controlled, follow-up study</TI>
<SO>Rheumatology International</SO>
<YR>2002</YR>
<VL>21</VL>
<PG>218-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nguyen-1997" NAME="Nguyen 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nguyen M, Revel M, Dougados M</AU>
<TI>Prolonged effects of 3 week therapy in a spa resort on lumbar spine, knee and hip osteoarthritis: follow-up after 6 months. A randomised controlled trial</TI>
<SO>British Journal of Rheumatology</SO>
<YR>1997</YR>
<VL>36</VL>
<PG>77-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sukenik-1999" NAME="Sukenik 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sukenik S, Flusser D, Codish S, Abu-Shakra M</AU>
<TI>Balneotherapy at the Dead Sea area for knee osteoarthritis</TI>
<SO>IMAJ</SO>
<YR>1999</YR>
<VL>1</VL>
<PG>83-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tishler-2004" NAME="Tishler 2004" YEAR="2004">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Tishler M, Rosenberg O, Levy O, Elias I, Amit-Vazina M</AU>
<TI>The effect of balneotherapy on osteoarthritis. Is an intermittent regimen effective?</TI>
<SO>European Journal of Internal Medicine</SO>
<YR>2004</YR>
<VL>15</VL>
<PG>93-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wigler-1995" NAME="Wigler 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wigler I, Elkayam O, Paran D, Yaron M</AU>
<TI>Spa therapy for gonarthrosis: a prospective study</TI>
<SO>Rheumatology International</SO>
<YR>1995</YR>
<VL>15</VL>
<PG>65-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Baldwin-1972" NAME="Baldwin 1972" YEAR="1972">
<REFERENCE NOTES="&lt;p&gt;Baldwin J. Pool therapy compared with individual home exercise therapy for juvenile rheumatoid arthritic patients. Physiother 1972; 58: 230-1.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Baldwin J</AU>
<TI>Pool therapy compared with individual home exercise therapy for juvenile rheumatoid arthritic patients</TI>
<SO>Physiotherapy</SO>
<YR>1972</YR>
<VL>58</VL>
<PG>230-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Buskila-2001" NAME="Buskila 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Buskila D, Abu-Shakra M, Neumann L, Odes L, Shneider E, Flusser D, Sukenik S</AU>
<TI>Balneotherapy for fibromyalgia at the Dead Sea</TI>
<SO>Rheumaltology International</SO>
<YR>2001</YR>
<VL>20</VL>
<PG>105-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Danneskiold-1987" NAME="Danneskiold 1987" YEAR="1987">
<REFERENCE NOTES="&lt;p&gt;Danneskiold-Samsoe B, Lyngberg K, Risum T, Telling M. The effect of water exercise therapy given to patients with rheumatoid arthritis. Scand J Rehab Med 1987; 19: 31-5.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Danneskiold-Samsoe B, Lyngberg K, Risum T, Telling M</AU>
<TI>The effect of water exercise therapy given to patients with rheumatoid arthritis</TI>
<SO>Scandinavian Journal of Rehabilitation Medicine</SO>
<YR>1987</YR>
<VL>19</VL>
<PG>31-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ekmekcioglu-2002" NAME="Ekmekcioglu 2002" YEAR="2002">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Ekmekcioglu C, Strauss-Blasche G, Holzer F, Marktl W</AU>
<TI>Effect of sulphur baths on antioxidative defense systems, peroxide concentrations and lipid levels in patients with degenerative osteoarthritis</TI>
<SO>Forsch Komplementarmed Klass Naturheilk</SO>
<YR>2002</YR>
<VL>9</VL>
<NO>4</NO>
<PG>216-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Elkayam-2000" NAME="Elkayam 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Elkayam O, Ophir J, Brener S, Paran D, Wigler I, Efron D, Even-Paz Z, Politi Y, Yaron M</AU>
<TI>Immediate and delayed effects of treatment at the Dead Sea in patients with psoriatic arthritis</TI>
<SO>Rheumatology International</SO>
<YR>2000</YR>
<VL>19</VL>
<PG>77-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Estefan-1999" NAME="Estefan 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Estefan MY, El-Shabrawy O, Erian EY, Raslan H, Morcos SW</AU>
<TI>Environmental recuperation in "Safaga" on the Red Sea Coast was effective for rheumatoid arthritis</TI>
<SO>Journal of Clinical Rheumatology</SO>
<YR>1999</YR>
<VL>5</VL>
<NO>2</NO>
<PG>109-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Forestier-1970" NAME="Forestier 1970" YEAR="1970">
<REFERENCE NOTES="&lt;p&gt;Forestier F, Augy S. Rhumatismes et thermalisme une exp&amp;#8218;rience control&amp;#8218;e de 65 cas. Presse Thermale Climatique 1970; 107: 200-5. (French)&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Forestier F, Augy S</AU>
<TI>Rhumatismes et thermalisme une experience controlee de 65 cas (French)</TI>
<SO>Presse Thermale Climatique</SO>
<YR>1970</YR>
<VL>107</VL>
<PG>200-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Franke-2000" NAME="Franke 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Franke A, Reiner L, Pratzel HG, Franke T, Resch KL.</AU>
<TI>Long term efficacy of radon spa therapy in rheumatoid arthritis; a randomized sham-controlled study and follow-up</TI>
<SO>Rheumatology</SO>
<YR>2000</YR>
<VL>39</VL>
<PG>894-902</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gambichler-2001" NAME="Gambichler 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gambichler T, Rapp S, Senger E, Altmeyer P, Hoffmann K</AU>
<TI>Balneophototherapy of psoriasis: highly concentrated salt water versus tap water: a randomized, one-blind, right/left comparative study</TI>
<SO>Photodermatology Photoimmunology &amp; Photomedicine</SO>
<YR>2001</YR>
<VL>17</VL>
<PG>22-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guillemin-2001" NAME="Guillemin 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Guillemin F, Virion JM, Escudier P, de Talancé N, Weryha G</AU>
<TI>Effects on osteoarthritis of spatherapy at Bourbonne-les-Bains</TI>
<SO>Joint Bone Spine</SO>
<YR>2001</YR>
<VL>68</VL>
<PG>499-503</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Halevy-2001" NAME="Halevy 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Halevy S, Giryes H, Friger M, Grossman N, Karpas Z, Sarov B, Sukenik S</AU>
<TI>The role of trace elements in psoriatic patients undergoing balneotherapy with Dead Sea bath salts</TI>
<SO>IMAJ</SO>
<YR>2001</YR>
<VL>3</VL>
<PG>828-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hall-1996" NAME="Hall 1996" YEAR="1996">
<REFERENCE NOTES="&lt;p&gt;Hall J, Skevington SM, Maddison PJ, Chapman K. A randomized and controlled trial of hydrotherapy in rheumatoid arthritis. Arthritis care and research 1996; 9: 206-15.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hall J, Skevington SM, Maddison PJ, Chapman K</AU>
<TI>A randomized and controlled trial of hydrotherapy in rheumatoid arthritis</TI>
<SO>Arthritis care and research</SO>
<YR>1996</YR>
<VL>9</VL>
<PG>206-15</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hill-1999" NAME="Hill 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hill S, Eckett MJH, Paterson C, Harkness EF</AU>
<TI>A pilot study to evaluate the effects of floatation spa treatments on patients with osteoarthritis</TI>
<SO>Complementary Therapies in Medicine</SO>
<YR>1999</YR>
<VL>7</VL>
<PG>235-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Klemm-1971" NAME="Klemm 1971" YEAR="1971">
<REFERENCE NOTES="&lt;p&gt;Klemm C, Fricke R, Schattenkirchner M, Treiber W, Mathies H. [Effects and side effects of 3-chlor-4-allyloxy-phenylacetic acid (Mervan) in therapeutic study of rheumatic diseases.] Z. Rheumaforsch 1971; 30: 17-25.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Klemm C, Fricke R, Schattenkirchner M, Treiber W, Mathies H</AU>
<TI>[Effects and side effects of 3-chlor-4-allyloxy-phenylacetic acid (Mervan) in therapeutic study of rheumatic diseases.]</TI>
<SO>Rheumaforsch</SO>
<YR>1971</YR>
<VL>30</VL>
<PG>17-25</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Landewe-1992" NAME="Landewe 1992" YEAR="1992">
<REFERENCE NOTES="&lt;p&gt;Landewe RBM, Peeters R, Verreusel RLP, Masek BA, Goei The HS. [No difference in effectiveness measured between treatment in a thermal bath and in an exercise bath in patients with rheumatoid arthritis.]. Ned T Geneesk 1992; 139: 173-7 (Dutch)&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Landewe RBM, Peeters R, Verreusel RLP, Masek BA, Goei The HS</AU>
<TI>[No difference in effectiveness measured between treatment in a thermal bath and in an exercise bath in patients with rheumatoid arthritis.] (Dutch)</TI>
<SO>Nederlands Tijdschrift voor Geneeskunde</SO>
<YR>1992</YR>
<VL>139</VL>
<PG>173-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Neumann-2001" NAME="Neumann 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Neumann L, Sukenik S, Bolotin A, Abu-Shakra M, Amir M, Flusser D, Buskila D</AU>
<TI>The effect of balneotherapy at the DeadSea on the quality of life of patients with fibromyalgia syndrome</TI>
<SO>Clinical Rheumatology</SO>
<YR>2001</YR>
<VL>20</VL>
<PG>15-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nicholls-1990" NAME="Nicholls 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Nicholls E, Ahern M, Simionato E, Bovill I. Assessment of hydrotherapy as a therapeutic modality in rheumatic diseases. Proceedings 3rd Int Physiotherapy Congress, Hong Kong 1990: 630-5. Sydney: Link Printing Pty Ltd, 1990.&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Nicholls E, Ahern M, Simionato E, Bovill I</AU>
<TI>Assessment of hydrotherapy as a therapeutic modality in rheumatic diseases</TI>
<SO>Proceedings 3rd Int Physiotherapy Congress, Hong Kong</SO>
<YR>1990</YR>
<PG>630-5</PG>
<PB>Link Printing Pty Ltd</PB>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rijswijk-1992" NAME="Rijswijk 1992" YEAR="1992">
<REFERENCE NOTES="&lt;p&gt;Rijswijk MH van. [A prospective study of the effectiveness of thermal bath treatments in patients with rheumatoid arthritis.]. Ned T Geneesk 1992; 136: 163-4. (Dutch)&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rijswijk MH van</AU>
<TI>[A prospective study of the effectiveness of thermal bath treatments in patients with rheumatoid arthritis.] (Dutch)</TI>
<SO>Nederlands tijdschrift voor geneeskunde</SO>
<YR>1992</YR>
<VL>136</VL>
<PG>163-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Steiner-1979" NAME="Steiner 1979" YEAR="1979">
<REFERENCE NOTES="&lt;p&gt;Steiner FJF, Valkenburg HA, Stadt RJ van der, Stoyanova-Drenska M, Zant J. [Balneology treatment of patients with rheumatoid arthritis.]. Ned T Geneesk 1979; 123: 661-4. (Dutch)&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Steiner FJF, Valkenburg HA, Stadt RJ van der, Stoyanova-Drenska M, Zant J</AU>
<TI>[Balneology treatment of patients with rheumatoid arthritis.] (Dutch)</TI>
<SO>Nederlands tijdschrift voor geneeskunde</SO>
<YR>1979</YR>
<VL>123</VL>
<PG>661-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Strauss_x002d_Blasche-2000" NAME="Strauss-Blasche 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Strauss-Blasche G, Ekmekcioglu C, Klammer N, Marktl W</AU>
<TI>The change of well-being associated with spa therapy</TI>
<SO>Forschende Komplementärmedizin und Klassische Naturheilkunde</SO>
<YR>2000</YR>
<VL>7</VL>
<PG>269-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sukenik-1990a" NAME="Sukenik 1990a" YEAR="1990a">
<REFERENCE NOTES="&lt;p&gt;Sukenik S, Neumann L, Buskila D, Kleiner-Baumgarten A, Zimlichman S, Horowitz J. Dead Sea salt baths for the treatment of rheumatoid arthritis. Clin Exp Rheumatol 1990a; 8: 353-7.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sukenik S, Neumann L, Buskila D, Kleiner-Baumgarten A, Zimlichman S, Horowitz J</AU>
<TI>Dead Sea salt baths for the treatment of rheumatoid arthritis</TI>
<SO>Clinical and Experimental Rheumatology</SO>
<YR>1990</YR>
<VL>8</VL>
<PG>353-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sukenik-1990b" NAME="Sukenik 1990b" YEAR="1990b">
<REFERENCE NOTES="&lt;p&gt;Sukenik S, Buskila D, Neumann L, Kleiner-Baumgarten A, Zimlichman S, Horowitz J. Sulphur baths and mud pack treatment for rheumatoid arthritis at the Dead Sea area. Ann Rheum Dis 1990b; 49: 99-102.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sukenik S, Buskila D, Neumann L, Kleiner-Baumgarten A, Zimlichman S, Horowitz J</AU>
<TI>Sulphur baths and mud pack treatment for rheumatoid arthritis at the Dead Sea area</TI>
<SO>Annals of Rheumatic Diseases</SO>
<YR>1990</YR>
<VL>49</VL>
<PG>99-102</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sukenik-1994b" NAME="Sukenik 1994b" YEAR="1994b">
<REFERENCE NOTES="&lt;p&gt;Sukenik S, Giryes H, Halevy S, Neumann L, Flusser D, Buskila D. Treatment of psoriatic arthritis at the Dead Sea. J. Rheumatol 1994b; 21: 1305-9.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sukenik S, Giryes H, Halevy S, Neumann L, Flusser D, Buskila D</AU>
<TI>Treatment of psoriatic arthritis at the Dead Sea</TI>
<SO>Rheumatology</SO>
<YR>1994</YR>
<VL>21</VL>
<PG>1305-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sukenik-1995" NAME="Sukenik 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;Sukenik S, Neumann L, Flusser D, Kleiner-Baumgarten A, Buskila D. Balneotherapy for rheumatoid arthritis at the Dead Sea. Isr J Med Sci 1995; 31: 210-4.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sukenik S, Neumann L, Flusser D, Kleiner-Baumgarten A, Buskila D</AU>
<TI>Balneotherapy for rheumatoid arthritis at the Dead Sea</TI>
<SO>Israelian Journal of Medicine and Science</SO>
<YR>1995</YR>
<VL>31</VL>
<PG>210-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sukenik-2001" NAME="Sukenik 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sukenik S, Baradin R, Codish S, Neumann L, Flusser D, Abu-Shakra M, Buskila D</AU>
<TI>Balneotherapy at the Dead Sea area for patients with psoriatic arthritis and concomitant fibromyalgia</TI>
<SO>IMAJ</SO>
<YR>2001</YR>
<VL>3</VL>
<PG>147-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Svarcova-1990" NAME="Svarcova 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Svarcova J von, Hofta T, Kouba A, Trnavsky K, Zvorov J. Beeinflussung der Schmerzsymptomatik im Fussbereich bei Patienten mit Rheumatoid-Arthritis durch unterschiedliche Physiotherapiemittel. Z Physiother 1990; 42: 109-12. (German)&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Svarcova J von, Hofta T, Kouba A, Trnavsky K, Zvorov J</AU>
<TI>Beeinflussung der Schmerzsymptomatik im Fussbereich bei Patienten mit Rheumatoid-Arthritis durch unterschiedliche Physiotherapiemittel (German)</TI>
<SO>Zeitschrift für Physiotherapie</SO>
<YR>1990</YR>
<VL>42</VL>
<PG>109-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sylvester-1989" NAME="Sylvester 1989" YEAR="1989">
<REFERENCE NOTES="&lt;p&gt;Sylvester KL. Investigation of the effect of hydrotherapy in the treatment of osteoarthritic hips. Clin Rehab 1989; 4: 223-8.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sylvester KL</AU>
<TI>Investigation of the effect of hydrotherapy in the treatment of osteoarthritic hips</TI>
<SO>Clinical Rehabilitation</SO>
<YR>1989</YR>
<VL>4</VL>
<PG>223-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Szucz-1989" NAME="Szucz 1989" YEAR="1989">
<REFERENCE NOTES="&lt;p&gt;Szucz L, Ratko I, Lesko T, Szoor I, Genti G, Balint G. Double blind trial on the effectiveness of the Puspokladany thermal water on arthrosis of the knee joints. The Roy Soc Health J. 1989; 109: 7-9.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Szucz L, Ratko I, Lesko T, Szoor I, Genti G, Balint G</AU>
<TI>Double blind trial on the effectiveness of the Puspokladany thermal water on arthrosis of the knee joints</TI>
<SO>Journal of The Royal Society for the Promotion of Health</SO>
<YR>1989</YR>
<VL>109</VL>
<PG>7-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-van-Tubbergen-2001" NAME="van Tubbergen 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van Tubbergen A, Landewé R, van der Heijde D, Hidding A, Wolter N, Asscher M, Falkenbach A, Genth E, Goei Thé H, van der Linden S</AU>
<TI>Combined spa-exercise therapy is effective in patients with ankylosing spondylitis: a randomized controlled trial</TI>
<SO>Arthritis Care and Research</SO>
<YR>2001</YR>
<VL>45</VL>
<PG>430-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Youn-1998" NAME="Youn 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Youn AI, Kim BK, Suh DH</AU>
<TI>The effectivieness of modified ingram therapy compared with severity of psoriasis</TI>
<SO>The Journal of Dermatology</SO>
<YR>1998</YR>
<VL>25</VL>
<PG>112-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-_x00d6_zcelik-2000" NAME="Özcelik 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Özcelik S, Polat HH, Akyol M, Yalcin AN, Özcelik D, Marufinah M</AU>
<TI>Kangal hot spring with fish and psoriasis treatment</TI>
<SO>The Journal of Dermatology</SO>
<YR>2000</YR>
<VL>27</VL>
<PG>386-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Athanasiu-1972" NAME="Athanasiu 1972" YEAR="1972">
<REFERENCE NOTES="&lt;p&gt;Athanasiu P, Petrescu A, Surdan C, Moisa I. [Effect of mineral water and balneological treatment with iodated and sulfurated water on rickettsial, pararickettsial and adenoviral antibodies in patients with associated pulmonary and rheumatic chronic diseases.] Stud Cercet Virusol 1972; 23: 9-12. (Romanian)&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Athanasiu P, Petrescu A, Surdan C, Moisa I</AU>
<TI>[Effect of mineral water and balneological treatment with iodated and sulfurated water on rickettsial, pararickettsial and adenoviral antibodies in patients with associated pulmonary and rheumatic chronic diseases.] (Romanian)</TI>
<SO>Studii si cercetari de virusologie</SO>
<YR>1972</YR>
<VL>23</VL>
<PG>9-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Horvath-1967" NAME="Horvath 1967" YEAR="1967">
<REFERENCE NOTES="&lt;p&gt;Horvath G. [Effect of hyperthermic baths in diseases of the locomotive system.] Fysiatr Revmatol Vestn 1967; 45: 277-80. (Czech)&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Horvath G</AU>
<TI>[Effect of hyperthermic baths in diseases of the locomotive system.] (Czech)</TI>
<SO>Fysiatrický a reumatologický vestník</SO>
<YR>1967</YR>
<VL>45</VL>
<PG>277-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kabanov-1965" NAME="Kabanov 1965" YEAR="1965">
<REFERENCE NOTES="&lt;p&gt;Kabanov SE. [Effectiveness of the treatment of dystrophic (non-infective) polyarthritis in Sochi-Matseta spa with special reference to remote results.] Vopr Rev. 1965; 5: 52-8 .(Russian)&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kabanov SE</AU>
<TI>[Effectiveness of the treatment of dystrophic (non-infective) polyarthritis in Sochi-Matseta spa with special reference to remote results.] (Russian)</TI>
<SO>Voprosy revmatizma</SO>
<YR>1965</YR>
<VL>5</VL>
<PG>52-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lazowski-1966" NAME="Lazowski 1966" YEAR="1966">
<REFERENCE NOTES="&lt;p&gt;Lazowski Z, Gutowska-Grzegorczyk G, Romicka A, Marchwicki I. [Tentative assess-ment of rehabilitation with particular consideration of the effects of balneotherapy on the course of rheumatoid arthritis in children.] Reumatologia. 1966; 4: 321-9. (Polish)&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lazowski Z, Gutowska-Grzegorczyk G, Romicka A, Marchwicki I</AU>
<TI>[Tentative assessment of rehabilitation with particular consideration of the effects of balneotherapy on the course of rheumatoid arthritis in children.] (Polish)</TI>
<SO>Reumatologia</SO>
<YR>1966</YR>
<VL>4</VL>
<PG>321-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Litvinenko-1977" NAME="Litvinenko 1977" YEAR="1977">
<REFERENCE NOTES="&lt;p&gt;Litvinenko AG, Perminov IA, Poluden' EP, Oprenko BI, Pavlova ES. [Evaluation of efficacy of balneotherapy methods in patients with rheumatoid polyarthritis.] Vrach Delo 1977; 5: 101-4. (Russian)&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Litvinenko AG, Perminov IA, Poluden' EP, Oprenko BI, Pavlova ES</AU>
<TI>[Evaluation of efficacy of balneotherapy methods in patients with rheumatoid polyarthritis.] (Russian)</TI>
<SO>Vrachebnoe delo</SO>
<YR>1977</YR>
<VL>5</VL>
<PG>101-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mackiewicz-1966" NAME="Mackiewicz 1966" YEAR="1966">
<REFERENCE NOTES="&lt;p&gt;Mackiewicz S, Sternalova L. [Evaluation of the balneological treatment of children with progressive juvenile polyarthritis.] Fysiatr Revmatol Vestn 1966; 44: 324-7. (Czech)&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mackiewicz S, Sternalova L</AU>
<TI>[Evaluation of the balneological treatment of children with progressive juvenile polyarthritis.] (Czech)</TI>
<SO>Fysiatrický a reumatologický vestník</SO>
<YR>1966</YR>
<VL>44</VL>
<PG>324-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mar_x0027_iasis-1987" NAME="Mar'iasis 1987" YEAR="1987">
<REFERENCE NOTES="&lt;p&gt;Mar'iasis ED, Militenko SA, Shalygina IE.[ Therapeutic efficacy of dry-air radon baths in the rehabilitation of patients with psoriatic arthritis.] Vopr Kurortol Fizioter Lech Fiz Kult 1987; 6: 37-9. (Russian)&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mar'iasis ED, Militenko SA, Shalygina IE</AU>
<TI>[ Therapeutic efficacy of dry-air radon baths in the rehabilitation of patients with psoriatic arthritis.] (Russian)</TI>
<SO>Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury</SO>
<YR>1987</YR>
<VL>6</VL>
<PG>37-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nobunaga-1992" NAME="Nobunaga 1992" YEAR="1992">
<REFERENCE NOTES="&lt;p&gt;Nobunaga M. Balneotherapy of patients with rheumatoid arthritis. 1992; 3-8. (Japanese with English abstract, unable to trace the journal or congress it is published. The original report is in the authors possession ).&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nobunaga M</AU>
<TI>Balneotherapy of patients with rheumatoid arthritis</TI>
<SO>Japanese with English abstract, unable to trace the journal or congress it is published. The original report is in the authors possession</SO>
<YR>1992</YR>
<PG>3-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-O_x0027_Hare-1985" NAME="O'Hare 1985" YEAR="1985">
<REFERENCE NOTES="&lt;p&gt;O'Hare JP, Heywood A, Summerhayes C. et al. Observations on the effect of immersion in bath spa water. BMJ 1985; 291: 1747-51.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>O'Hare JP, Heywood A, Summerhayes C, et al</AU>
<TI>Observations on the effect of immersion in bath spa water</TI>
<SO>Brittish Medical Journal</SO>
<YR>1985</YR>
<VL>291</VL>
<PG>1747-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Perel_x0027_muter-1976" NAME="Perel'muter 1976" YEAR="1976">
<REFERENCE NOTES="&lt;p&gt;Perel'muter DL, Trofimova TM, Drinevskii NP, Mel'nikov AA, Kotikov VE. [Effectiveness of step-by-step treatment of patients in early stage of rheumatoid arthritis at the AMS] USSR Institute of Rheumatism and in Eupatoria health resort. Vopr Revm 1976; 3: 27-31. (Russian)&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Perel'muter DL, Trofimova TM, Drinevskii NP, Mel'nikov AA, Kotikov VE</AU>
<TI>[Effectiveness of step-by-step treatment of patients in early stage of rheumatoid arthritis at the AMS] USSR Institute of Rheumatism and in Eupatoria health resort] (Russian)</TI>
<SO>Voprosy revmatizma</SO>
<YR>1976</YR>
<VL>3</VL>
<PG>27-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pshetakovskii-1971" NAME="Pshetakovskii 1971" YEAR="1971">
<REFERENCE NOTES="&lt;p&gt;Pshetakovskii IL. [Effect of radon water therapy at the Khmel'nik health resort on the cardiovascular system in patients with rheumatoid arthritis.] Vopr Kurortol Fizioter Lech Fiz Kult 1971; 36: 222-6. (Russian)&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pshetakovskii IL</AU>
<TI>[Effect of radon water therapy at the Khmel'nik health resort on the cardiovascular system in patients with rheumatoid arthritis.] (Russian)</TI>
<SO>Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury</SO>
<YR>1971</YR>
<VL>36</VL>
<PG>222-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rybnikov-1965" NAME="Rybnikov 1965" YEAR="1965">
<REFERENCE NOTES="&lt;p&gt;Rybnikov NI, Novitskii GA. [Vascular changes as indices of the effectiveness of treatment of polyarthritis of various etiology with the radon-containing mineral waters of Chmielnik.] Vopr Kurortol Fizioter Lech Fiz Kult 1965; 30: 462-3. (Russian)&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rybnikov NI, Novitskii GA</AU>
<TI>[Vascular changes as indices of the effectiveness of treatment of polyarthritis of various etiology with the radon-containing mineral waters of Chmielnik.] (Russian)</TI>
<SO>Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury</SO>
<YR>1965</YR>
<VL>30</VL>
<PG>462-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sukenik-1990c" NAME="Sukenik 1990c" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Sukenik S. [Balneological (spa)therapy for rheumatic diseases.] Harefuah 1990c; 119: 167-170. (Hebrew).&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sukenik S</AU>
<TI>[Balneological (spa)therapy for rheumatic diseases.] (Hebrew)</TI>
<SO>Harefuah</SO>
<YR>1990</YR>
<VL>119</VL>
<PG>167-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sukenik-1995a" NAME="Sukenik 1995a" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;Sukenik S, Mayo A, Neumann L, Flusser D, Kleiner-Baumgarten A, Buskila D.[ Dead Sea baths salts for the treatment of knee ostoearthritis.] Harefuah 1995; 129: 100-3,159,158. (Hebrew).&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sukenik S, Mayo A, Neumann L, Flusser D, Kleiner-Baumgarten A, Buskila D</AU>
<TI>[ Dead Sea baths salts for the treatment of knee osteoarthritis.] (Hebrew)</TI>
<SO>Harefuah</SO>
<YR>1995</YR>
<VL>129</VL>
<PG>100-3,159,158</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Susta-1975" NAME="Susta 1975" YEAR="1975">
<REFERENCE NOTES="&lt;p&gt;Susta A, Pavelka K, Bremova A, Salavcova V, Svandova H, Richter M. [Controlled clinical trial with Benetazone (Spofa) during spa treatment.] Fysiatr Revmatol Vestn 1975; 53: 3-11. (Czech)&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Susta A, Pavelka K, Bremova A, Salavcova V, Svandova H, Richter M</AU>
<TI>[Controlled clinical trial with Benetazone (Spofa) during spa treatment.] (Czech)</TI>
<SO>Fysiatrický a reumatologický vestník</SO>
<YR>1975</YR>
<VL>53</VL>
<PG>3-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Taletene-1984" NAME="Taletene 1984" YEAR="1984">
<REFERENCE NOTES="&lt;p&gt;Taletene IP, Gaigalene BA. [Effect of combined chrisanol and balneological treatment on the clinical indicators and permeability of the synovian membrane in patients with rheumatoid arthritis.] Vopr Kurortol Fizioter Lech Fiz Kult 1984; 2: 28-31. (Russian)&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Taletene IP, Gaigalene BA</AU>
<TI>[Effect of combined chrisanol and balneological treatment on the clinical indicators and permeability of the synovian membrane in patients with rheumatoid arthritis.] (Russian)</TI>
<SO>Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury</SO>
<YR>1984</YR>
<VL>2</VL>
<PG>28-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Timofeev-1973" NAME="Timofeev 1973" YEAR="1973">
<REFERENCE NOTES="&lt;p&gt;Timofeev AV, Shautsukova LK, Shautsukova LZ. [Mathematical evaluation of the effectiveness of balneotherapy and the differential diagnosis of rheumatoid and rheumatic polyarthritis.] Vestn Akad Med Nauk SSSR 1973; 28: 85-7. (Russian)&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Timofeev AV, Shautsukova LK, Shautsukova LZ</AU>
<TI>[Mathematical evaluation of the effectiveness of balneotherapy and the differential diagnosis of rheumatoid and rheumatic polyarthritis.] (Russian)</TI>
<SO>Vestnik Akademii meditsinskikh nauk SSSR</SO>
<YR>1973</YR>
<VL>28</VL>
<PG>85-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Veinpalu_x002d_EIu-1979" NAME="Veinpalu-EIu 1979" YEAR="1979">
<REFERENCE NOTES="&lt;p&gt;Veinpalu-EIu, Trink RF, Veinpalu LE. [Factors affecting the results of the overall treatment of rheumatoid arthritis at mud therapy health resorts.] Vopr Kurortol Fizioter Lech Fiz Kult 1979; 1: 27-31. (Russian)&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Veinpalu-EIu, Trink RF, Veinpalu LE</AU>
<TI>[Factors affecting the results of the overall treatment of rheumatoid arthritis at mud therapy health resorts.] (Russian)</TI>
<SO>Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury</SO>
<YR>1979</YR>
<VL>1</VL>
<PG>27-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zaitseva-1979" NAME="Zaitseva 1979" YEAR="1979">
<REFERENCE NOTES="&lt;p&gt;Zaitseva VI, Bersudskaia SL, Gudilina VG, Petrova VI, Khakimdzhanov AKh. [Experience with the balneological treatment of rheumatoid arthritis at a Republic hospital.] Vopr Kurortol Fizioter Lech Fiz Kult 1979; 1: 51-3. (Russian)&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zaitseva VI, Bersudskaia SL, Gudilina VG, Petrova VI, Khakimdzhanov AKh</AU>
<TI>[Experience with the balneological treatment of rheumatoid arthritis at a Republic hospital.] (Russian)</TI>
<SO>Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury</SO>
<YR>1979</YR>
<VL>1</VL>
<PG>51-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zavadiak-1976" NAME="Zavadiak 1976" YEAR="1976">
<REFERENCE NOTES="&lt;p&gt;Zavadiak M. [Effectiveness of treatment of patients with rheumatoid polyarthritis at the balneologic resort Siniak.] Vrach Delo 1976; 10: 105-9. (Russian)&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zavadiak M</AU>
<TI>[Effectiveness of treatment of patients with rheumatoid polyarthritis at the balneologic resort Siniak.] (Russian)</TI>
<SO>Vrachebnoe delo</SO>
<YR>1976</YR>
<VL>10</VL>
<PG>105-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES>
<ADDITIONAL_REFERENCES>
<REFERENCE ID="REF-Balint-1993" NAME="Balint 1993" NOTES="&lt;p&gt;Balint G, Bender T, Szab&amp;#162; E. Spa treatment in arthritis (correspondence). J Rheumatol 1993; 20: 1623-5.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Balint G, Bender T, Szab¢ E</AU>
<TI>Spa treatment in arthritis (correspondence)</TI>
<SO>Journal of Rheumatology</SO>
<YR>1993</YR>
<VL>20</VL>
<PG>1623-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bellamy-1999" NAME="Bellamy 1999" TYPE="JOURNAL_ARTICLE">
<AU>Bellamy N</AU>
<TI>Clinical trials design: structure modifying agents for osteoarthritis. Future guidelines: areas for development</TI>
<SO>Osteoarthritis and Cartilage</SO>
<YR>1999</YR>
<VL>7</VL>
<PG>424-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Brosseau-2002" NAME="Brosseau 2002" TYPE="JOURNAL_ARTICLE">
<AU>Brosseau L, Macleay L, Robinson V, Casimiro L, Pelland L, Wells G, Tugwell P, McGowan J</AU>
<TI>Efficacy of balneotherapy for osteoarthritis of the knee: a systematic review</TI>
<SO>Physical Therapy Reviews</SO>
<YR>2002</YR>
<VL>7</VL>
<PG>209-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cosh-1982" NAME="Cosh 1982" NOTES="&lt;p&gt;Cosh JA. The rheumatologist and the spa: a personal review. The Roy Soc Health J 1982; 102: 189-92.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Cosh JA</AU>
<TI>The rheumatologist and the spa: a personal review</TI>
<SO>The Royal Society of Health Journal</SO>
<YR>1982</YR>
<VL>102</VL>
<PG>189-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fam-1991" NAME="Fam 1991" NOTES="&lt;p&gt;Fam AG. Spa treatment in arthritis: a rheumatologist's view (editorial).J Rheumatol 1991;18:1775-7.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Fam AG</AU>
<TI>Spa treatment in arthritis: a rheumatologist's view (editorial)</TI>
<SO>Journal of Rheumatology</SO>
<YR>1991</YR>
<VL>18</VL>
<PG>1775-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fife-1991" NAME="Fife 1991" TYPE="JOURNAL_ARTICLE">
<AU>Fife RS, Brandt KD, Braunstein EM, Katz BP, Shelbourne KD, Kalasinski LA, Ryan S</AU>
<TI>Relationship between arthroscopic evidence of cartilage damage and radiographic evidence of joint space narrowing in early osteoarthritis of the knees</TI>
<SO>Arthritis and Rheumatology</SO>
<YR>1991</YR>
<VL>34</VL>
<NO>4</NO>
<PG>377-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fioravanti-2003" NAME="Fioravanti 2003" TYPE="JOURNAL_ARTICLE">
<AU>Fioravanti A, Valenti M, Altobelli E, Di Orio F, Nappi G, Crisanti A, Cantarini L, Marcolongo R</AU>
<TI>Clinical efficacy and cost-effectiveness evidence of SPA therapy in osteoarthritis. The results of "Naiade" Italian project</TI>
<SO>Panminerva Madicine</SO>
<YR>2003</YR>
<VL>45</VL>
<NO>3</NO>
<PG>211-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jackson-1990" NAME="Jackson 1990" NOTES="&lt;p&gt;Jackson R. Waters and spas in the classical world. Medical History (suppl) 1990; 10: 1-13.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Jackson R</AU>
<TI>Waters and spas in the classical world</TI>
<SO>Medical History (suppl)</SO>
<YR>1990</YR>
<VL>10</VL>
<PG>1-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jagger-1984" NAME="Jagger 1984" NOTES="&lt;p&gt;Jagger M, Zmood D. Hydrotherapy by physiotherapists in a community health centre. Aust Fam Phys 1984; 13: 878-881.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Jagger M, Zmood D</AU>
<TI>Hydrotherapy by physiotherapists in a community health centre</TI>
<SO>Australian Family Physician</SO>
<YR>1984</YR>
<VL>13</VL>
<PG>878-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Johnson-1990" NAME="Johnson 1990" TYPE="JOURNAL_ARTICLE">
<AU>Johnson RH</AU>
<TI>Arthur Stanley Wohlmann, the first government balneologist in New Zealand</TI>
<SO>Medical History Supplement</SO>
<YR>1990</YR>
<VL>10</VL>
<PG>114-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lau-1997" NAME="Lau 1997" TYPE="JOURNAL_ARTICLE">
<AU>Lau J, Ioannidis JP, Schmid CH</AU>
<TI>Quantitative synthesis in systematic reviews</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1997</YR>
<VL>127</VL>
<NO>9</NO>
<PG>820-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nicholas-1994" NAME="Nicholas 1994" NOTES="&lt;p&gt;Nicholas JJ. Physical modalities in rheumatological rehabilitation; review article. Arch Phys Med Rehab 1994; 75: 994-1001.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Nicholas JJ</AU>
<TI>Physical modalities in rheumatological rehabilitation; review article</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>1994</YR>
<VL>75</VL>
<PG>994-1001</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Peyron-1993" NAME="Peyron 1993" TYPE="JOURNAL_ARTICLE">
<AU>Peyron JG</AU>
<TI>Intraarticular hyaluronan injections in the treatment of oseoarthritis: state of the art review</TI>
<SO>Journal of Rheumatology</SO>
<YR>1993</YR>
<VL>39</VL>
<PG>10-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pham-2003" NAME="Pham 2003" TYPE="JOURNAL_ARTICLE">
<AU>Pham T, van der Heijde D, Lassere M, Altman RD, Anderson JJ, Bellamy N, Hochberg M, Simon L, Strand V, Woodworth T, Dougados M; OMERACT-OARSI</AU>
<TI>Outcome variables for osteoarthritis clinical trials: the OMERACT-OARSI set of responder criteria</TI>
<SO>The Journal of Rheumatology</SO>
<YR>2003</YR>
<VL>30</VL>
<NO>7</NO>
<PG>1648-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Robinson-2002" NAME="Robinson 2002" TYPE="JOURNAL_ARTICLE">
<AU>Robinson KA, Dickersin K</AU>
<TI>Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed</TI>
<SO>International Journal of Epidemiology</SO>
<YR>2002</YR>
<VL>31</VL>
<PG>150-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Simon-1981" NAME="Simon 1981" NOTES="&lt;p&gt;Simon L, Blotman F. Exercise therapy and hydrotherapy in the treatment of the rheumatic diseases. Clin in Rheum Diseases 1981; 7: 337-47.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Simon L, Blotman F</AU>
<TI>Exercise therapy and hydrotherapy in the treatment of the rheumatic diseases</TI>
<SO>Clinic in Rheumatic Diseases</SO>
<YR>1981</YR>
<VL>7</VL>
<PG>337-47</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Smidt-2002" NAME="Smidt 2002" TYPE="JOURNAL_ARTICLE">
<AU>Smidt N, Assendelft WJ, van der Windt DA, Hay EM, Buchbinder R, Bouter LM</AU>
<TI>Corticosteroid injections for lateral epicondylitis: a systematic review</TI>
<SO>Pain</SO>
<YR>2002</YR>
<VL>96</VL>
<NO>1-2</NO>
<PG>23-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Solomon-1997" NAME="Solomon 1997" TYPE="JOURNAL_ARTICLE">
<AU>Solomon, DH, Bates DW, Panush RS, Katz JN</AU>
<TI>Costs, outcomes, and patient satisfaction by provider type for patients with rheumatic and musculoskeletal conditions: a critical review of the literature and proposed methodologic standards</TI>
<SO>Annals of Internal Medicine</SO>
<YR>1997</YR>
<VL>127</VL>
<NO>1</NO>
<PG>52-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sukenik-1994a" NAME="Sukenik 1994a" NOTES="&lt;p&gt;Sukenik S. Spa treatment for arthritis at the Dead Sea area. Editorial. Isr J Med Sci 1994a; 30: 919-921.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Sukenik S</AU>
<TI>Spa treatment for arthritis at the Dead Sea area. Editorial</TI>
<SO>Israelian Journal of Medical Science</SO>
<YR>1994</YR>
<VL>30</VL>
<PG>919-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tugwell-2004" NAME="Tugwell 2004" TYPE="BOOK">
<AU>Tugwell P, Shea B, Boers M, Brooks P, Simon L, Strand V, et al</AU>
<SO>Evidence-Based Rheumatology</SO>
<YR>2004</YR>
<PB>BMJ Books</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-v-Tubbergen-2001" NAME="v Tubbergen 2001" TYPE="JOURNAL_ARTICLE">
<AU>van Tubbergen A, Landewé R, van der Heijde D, Hidding A, Wolter N, Asscher M, Falkenbach A, Genth E, Goei Thé H, van der Linden S</AU>
<TI>Combined spa-exercise therapy is effective in patients with ankylosing spondylitis: a randomized controlled trial</TI>
<SO>Arthritis Care and Research</SO>
<YR>2001</YR>
<VL>45</VL>
<PG>430-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-v-Tubbergen-2002" NAME="v Tubbergen 2002" TYPE="JOURNAL_ARTICLE">
<AU>van Tubbergen A, van der Linden S</AU>
<TI>A brief history of spa therapy</TI>
<SO>Annals of Rheumatic Diseases</SO>
<YR>2002</YR>
<VL>61</VL>
<PG>273-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-v-Tulder-2003" NAME="v Tulder 2003" TYPE="JOURNAL_ARTICLE">
<AU>van Tulder M, Furlan A, Bombardier C, Bouter L, Editorial Board of the Cochrane Collaboration Back Review Group</AU>
<TI>Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group</TI>
<SO>Spine</SO>
<YR>2003</YR>
<VL>28</VL>
<PG>1290-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Verhagen-1998" NAME="Verhagen 1998" TYPE="JOURNAL_ARTICLE">
<AU>Verhagen AP, de Vet HCW, de Bie RA, Kessels, AGH, Boers M, Bouter LM, Knipschild PG</AU>
<TI>The Delphi list: a criteria list for quality assessment of randomised clinical trials for conducting systematic reviews developed by Delphi consensus</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>1998</YR>
<VL>51</VL>
<PG>1235-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Verhagen-2001" NAME="Verhagen 2001" TYPE="JOURNAL_ARTICLE">
<AU>Verhagen AP, de Vet HCW, de Bie RA, Boers M, van den Brandt PA</AU>
<TI>The art of quality assessment of RCTs included in systematic reviews</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2001</YR>
<VL>54</VL>
<NO>7</NO>
<PG>651-4</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES>
<REFERENCE ID="REF-Elkayam-1991" NAME="Elkayam 1991" NOTES="&lt;p&gt;Elkayam O, Wigler I, Tishler M, Rosenblum I, Caspi D, Segal R, Fishel B, Yaron M. Effect of spa therapy in Tiberias in patients with rheumatoid arthritis and ostoearthritis. J Rheumatol 1991; 18: 1799-1803.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Elkayam O, Wigler I, Tishler M, Rosenblum I, Caspi D, Segal R, Fishel B, Yaron M</AU>
<TI>Effect of spa therapy in Tiberias in patients with rheumatoid arthritis and ostoearthritis</TI>
<SO>Journal of Rheumatology</SO>
<YR>1991</YR>
<VL>18</VL>
<PG>1799-803</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Machtey" NAME="Machtey" NOTES="&lt;p&gt;Machtey I. Dead Sea balneology in osteoarthritis. In: Machtey I, ed. Second International Seminar on Treatment of Rheumatic Diseases. Boston. John Wricht PGS Inc. 1982: 161-166.&lt;/p&gt;" TYPE="BOOK">
<AU>Machtey I</AU>
<TI>Dead Sea balneology in osteoarthritis. In: Machtey I, ed. Second International Seminar on Treatment of Rheumatic Diseases. Boston. John Wricht PGS Inc</TI>
<PG>161-166</PG>
<IDENTIFIERS/>
</REFERENCE>
</PENDING_REFERENCES>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES>
<CHARACTERISTICS_OF_INCLUDED_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR STUDY_ID="STD-Allard-1998">
<CHAR_METHODS>
<P>RCT.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Northern France Spa. Rheumatic disease. 4% patients with RA, N=148</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>I: Spa therapy, n=74<BR/>C: No treatment, n=74<BR/>Also non-randomised Spa therapy group (n=72).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Medication<BR/>Costs</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>14 drop-out in I, 6 in C.<BR/>Study designed to evaluate costs. Overall quality score: 1</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Green-1993">
<CHAR_METHODS>
<P>RCT. Blinded outcome assessment.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>St James Hospital, Leeds, UK, radiographic hip OA, N=63</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>I: Deep pool baths twice weekly + home exercises twice daily, n=24. 25% male, mean age 65.7 yr.<BR/>C: Home exercises twice daily, n=23. 26% male, mean age 68 yr.<BR/>Treatment for 6 weeks. Follow-up at 9, 12 and 18 weeks.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain: VAS<BR/>Function<BR/>Range of Motion<BR/>Muscle strength</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>16 drop-outs. <BR/>Overall quality score: 3</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kov_x00e1_cs-2002">
<CHAR_METHODS>
<P>RCT. Blinded patients and outcome assessment.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Cserkeszölö health resort, Hungary. Clinically and radiologically established OA of the knee, N=70.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>I: Daily bathing in thermal water for 30 minutes for 15 days, n=31. <BR/>C: Daily bathing in tap water (placebo) for 30 min for 15 days, n=27.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain: VAS, 4-point Likert<BR/>Range of motion: goniometer<BR/>Function: stair climbing, 4-point Likert<BR/>Perceived recovery</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>12 drop-outs.<BR/>Only pre-post analysis<BR/>Overall quality score: 4</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Nguyen-1997">
<CHAR_METHODS>
<P>RCT. Observer was clearly aware of treatment allocation.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>France. Patients with knee, hip or lumbar spine OA, N=233</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>I: Spa treatment for 21 days, n=91. 22% male, mean age 64 yr, mean DOC 11 yr.<BR/>C: No treatment, routine maintained, n=97. 16% male, mean age 63, mean DOC 12 yr.<BR/>Follow-up at 24 wks.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain: VAS<BR/>Function: WDI, AIMS<BR/>Mobility<BR/>Medication</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>45 drop-outs directly after randomisation, 4 extra drop-outs after 24 weeks.<BR/>Overall quality score: 4</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Sukenik-1999">
<CHAR_METHODS>
<P>RCT. Blinded outcome assessment.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Outpatient clinic Soroca MC, Israel. Moderate or severe radiographic knee OA, N=40</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>I1: Sulphur baths, n=10. 20% male, mean age 63.2 yr, mean DOC 11.6 yr.<BR/>I2: Dead Sea Baths, n=10. 10% male, mean age 65.4 yr, mean DOC 9.2 yr.<BR/>I3: I1 + I2. n=10. 0% male, mean age 57.6 yr. mean DOC 9.3 yr.<BR/>C: No treatment, n=10. 11% male, mean age 65,9 yr, mean DOC 8.4 yr.<BR/>All treatments 20 min twice daily for 2 wks.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain: patient assessment of severity.<BR/>Function: Lequesne Index<BR/>Range of motion</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>3 drop-outs in I3, 1 in C.<BR/>Only pre-post analysis.<BR/>Overall quality score: 4</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Tishler-2004">
<CHAR_METHODS>
<P>RCT.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Israel. Patients with knee OA, N=72</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>I: Mineral baths once weekly for 6 weeks, n=48. 21% male, mean age 65.2 yr, mean DOC 8.6 yr.<BR/>C: No treatment, n=24. 21% male, mean age 63.1 yr, mean DOC 7.5 yr.<BR/>Follow-up at 10 weeks.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain (VAS), WOMAC, analgesic intake.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>4 dropouts in I. Pre-post analysis.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Wigler-1995">
<CHAR_METHODS>
<P>RCT. Blinded patients and outcome assessment.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Tiberias spa hotel, Israel. Moderate or severe radiographic knee OA. N=33</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>I: Mineral baths daily + mud packs on alternate days for 20 min, n=11. 9% male, mean age 66 yr, mean DOC 8 yr.<BR/>C1: Mineral baths daily + rinsed mud packs on alternate days, n=10. 10% male, mean age 63 yr, mean DOC 10 yr.<BR/>C2: tap water baths daily + rinsed mud packs on alternate days for 20 min, n=12. 16% male, mean age 65 yr, mean DOC 7 yr.<BR/>Treatment period of 2 weeks; Follow-up: 20 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain: VAS<BR/>Function: ISK</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>2 drop-outs.<BR/>Overall quality score: 6</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>OA = osteoarthritis, DOC = duration of complaints; VAS = visual analogue scale; WDI = Waddel Disability Index<BR/>HAQ = Health Assessment Questionnaire; ISK = index of severity knee osteoarthrosis; WOMAC = West Ontario and McMaster Universities OA Index<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Baldwin-1972">
<CHAR_REASON_FOR_EXCLUSION>
<P>No RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Buskila-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>No OA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Danneskiold-1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>No RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ekmekcioglu-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Outcome inappropriate</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Elkayam-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>No OA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Estefan-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Letter to the editor</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Forestier-1970">
<CHAR_REASON_FOR_EXCLUSION>
<P>No RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Franke-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>No OA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gambichler-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>No OA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Guillemin-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>No RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Halevy-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>No OA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hall-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>No OA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hill-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>No RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Klemm-1971">
<CHAR_REASON_FOR_EXCLUSION>
<P>Outcome inappropriate</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Landewe-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>No RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Neumann-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>No OA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Nicholls-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>No balneotherapy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Rijswijk-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>No RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Steiner-1979">
<CHAR_REASON_FOR_EXCLUSION>
<P>No RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Strauss_x002d_Blasche-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>No RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sukenik-1990a">
<CHAR_REASON_FOR_EXCLUSION>
<P>No OA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sukenik-1990b">
<CHAR_REASON_FOR_EXCLUSION>
<P>No OA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sukenik-1994b">
<CHAR_REASON_FOR_EXCLUSION>
<P>No RCT, no OA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sukenik-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>No OA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sukenik-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>No RCT, No OA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Svarcova-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>No RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sylvester-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>No balneotherapy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Szucz-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>No RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-van-Tubbergen-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>No OA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Youn-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>No RCT, no OA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-_x00d6_zcelik-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>No RCT, no OA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR STUDY_ID="STD-Athanasiu-1972">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Horvath-1967">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Kabanov-1965">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Lazowski-1966">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Litvinenko-1977">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Mackiewicz-1966">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Mar_x0027_iasis-1987">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Nobunaga-1992">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-O_x0027_Hare-1985">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Perel_x0027_muter-1976">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Pshetakovskii-1971">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Rybnikov-1965">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Sukenik-1990c">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Sukenik-1995a">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Susta-1975">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Taletene-1984">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Timofeev-1973">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Veinpalu_x002d_EIu-1979">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Zaitseva-1979">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<AWAITING_CHAR STUDY_ID="STD-Zavadiak-1976">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Allard-1998">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Green-1993">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kov_x00e1_cs-2002">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Nguyen-1997">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Sukenik-1999">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Tishler-2004">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wigler-1995">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES>
<ADDITIONAL_TABLE ID="TBL-01" NO="1">
<TITLE>Methodological quality</TITLE>
<TABLE COLS="10" ROWS="8">
<TR>
<TH>
<P>Study</P>
</TH>
<TH>
<P>Randomisation</P>
</TH>
<TH>
<P>Concealment</P>
</TH>
<TH>
<P>Baseline comparison</P>
</TH>
<TH>
<P>Eligibility criteria</P>
</TH>
<TH>
<P>Blinded outcome ass</P>
</TH>
<TH>
<P>Blinded careprovider</P>
</TH>
<TH>
<P>Blinded patient</P>
</TH>
<TH>
<P>Data presentation</P>
</TH>
<TH>
<P>Intention to treat</P>
</TH>
</TR>
<TR>
<TD>
<P>Allard '98</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Unclear</P>
</TD>
<TD>
<P>Unclear</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Unclear</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>Green '93</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Unclear</P>
</TD>
<TD>
<P>Unclear</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Unclear</P>
</TD>
<TD>
<P>Unclear</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>Kovács '02</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Unclear</P>
</TD>
<TD>
<P>Unclear</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Unclear</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>Nguyen '97</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Unclear</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>Sukenik '99</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Unclear</P>
</TD>
<TD>
<P>Unclear</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>Tishler '04</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Unclear</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Unclear</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
</TR>
<TR>
<TD>
<P>Wigler '95</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Unclear</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>Unclear</P>
</TD>
<TD>
<P>Yes</P>
</TD>
<TD>
<P>No</P>
</TD>
<TD>
<P>Yes</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" NO="2">
<TITLE>Clinical relevance table: pain at follow-up</TITLE>
<TABLE COLS="10" ROWS="14">
<TR>
<TH>
<P>Study</P>
</TH>
<TH>
<P>Treatment group</P>
</TH>
<TH>
<P>Outcome</P>
</TH>
<TH>
<P>N</P>
</TH>
<TH>
<P>Baseline mean</P>
</TH>
<TH>
<P>End of study mean</P>
</TH>
<TH>
<P>Abs benefit</P>
</TH>
<TH>
<P>Rel difference</P>
</TH>
<TH>
<P>Stat significance</P>
</TH>
<TH>
<P>Quality of evidence</P>
</TH>
</TR>
<TR>
<TD>
<P>Kovacs '02</P>
</TD>
<TD>
<P>E: Mineral baths</P>
</TD>
<TD>
<P>Pain (10 cm VAS)</P>
</TD>
<TD>
<P>31</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>diff: -0.29 (SD 1.22)</P>
</TD>
<TD>
<P>0.006 (0.0006%)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>Not sign</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>C: Placebo baths</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>27</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>diff: -0.296 (SD 0.78)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Nguyen '97</P>
</TD>
<TD>
<P>E: Mineral baths</P>
</TD>
<TD>
<P>Pain (100 mm VAS)</P>
</TD>
<TD>
<P>91</P>
</TD>
<TD>
<P>50 (SD 20)</P>
</TD>
<TD>
<P>41 (SD 28)</P>
</TD>
<TD>
<P>9 (0.09%)</P>
</TD>
<TD>
<P>18.5 %; NNT=5</P>
</TD>
<TD>
<P>Sign</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>C: Usual care</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>97</P>
</TD>
<TD>
<P>47 (SD 22)</P>
</TD>
<TD>
<P>50 (SD 24)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Sukenik '99</P>
</TD>
<TD>
<P>E: Sulphur baths</P>
</TD>
<TD>
<P>Pain (0-10)</P>
</TD>
<TD>
<P>10</P>
</TD>
<TD>
<P>6.1 (SD 1.6)</P>
</TD>
<TD>
<P>6.2 (SD 1.5)</P>
</TD>
<TD>
<P>0.4 (0.004%)</P>
</TD>
<TD>
<P>6.6%</P>
</TD>
<TD>
<P>Not sign</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>C: Control</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>9</P>
</TD>
<TD>
<P>6.1 (1.5)</P>
</TD>
<TD>
<P>6.6 (SD 1.5)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Sukenik '99</P>
</TD>
<TD>
<P>E: Dead Sea baths</P>
</TD>
<TD>
<P>Pain (0-10)</P>
</TD>
<TD>
<P>10</P>
</TD>
<TD>
<P>6.5 (SD 1.0)</P>
</TD>
<TD>
<P>6.1 (SD 1.0)</P>
</TD>
<TD>
<P>0.9 (0.009%)</P>
</TD>
<TD>
<P>14.8%</P>
</TD>
<TD>
<P>Not sign</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>C: Control</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>9</P>
</TD>
<TD>
<P>6.1 (SD 1.5)</P>
</TD>
<TD>
<P>6.6 (SD 1.5)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Sukenik '99</P>
</TD>
<TD>
<P>E: Sulphur + Dead Sea baths</P>
</TD>
<TD>
<P>Pain (0-10)</P>
</TD>
<TD>
<P>7</P>
</TD>
<TD>
<P>6.6 (SD 1.0)</P>
</TD>
<TD>
<P>5.7 (SD 1.7)</P>
</TD>
<TD>
<P>1.4 (0.014%)</P>
</TD>
<TD>
<P>23.0%</P>
</TD>
<TD>
<P>Not sign</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>C: Control</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>9</P>
</TD>
<TD>
<P>6.1 (SD 1.5)</P>
</TD>
<TD>
<P>6.6 (SD 1.5)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Tishler '04</P>
</TD>
<TD>
<P>E: Mineral baths</P>
</TD>
<TD>
<P>Pain (100 mm VAS)</P>
</TD>
<TD>
<P>48</P>
</TD>
<TD>
<P>64.8 (SD 22.3)</P>
</TD>
<TD>
<P>26.3 (SD 22.3)</P>
</TD>
<TD>
<P>37.6 (0.376%)</P>
</TD>
<TD>
<P>56.6 %; NNT=2</P>
</TD>
<TD>
<P>Sign</P>
</TD>
<TD>
<P>Silver</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>C: No treatment</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>24</P>
</TD>
<TD>
<P>68.1 (SD 23.3)</P>
</TD>
<TD>
<P>63.9 (SD 23.3)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Legend:</P>
</TD>
<TD>
<P>0-10 scale, 0 = no pain and 10 = severe pain<BR/>Sign = significant<BR/>Abs = absolute<BR/>Rel = relative<BR/>N = # of patients<BR/>NNT=number needed to treat (for an improvement of 15%)</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES">
<COMPARISON ID="CMP-001" NO="1">
<NAME>Mineral baths versus tap water baths</NAME>
</COMPARISON>
<COMPARISON ID="CMP-002" NO="2">
<NAME>Sulphur baths versus Dead Sea baths</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.01" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="30" TOTAL_2="30" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Function</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Sulphur</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Dead Sea</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.01.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>End of treatment</NAME>
<CONT_DATA CI_END="3.2000636346569067" CI_START="-3.2000636346569067" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="12.0" MEAN_2="12.0" ORDER="5921" SD_1="2.0" SD_2="4.76" SE="1.6327155294171731" STUDY_ID="STD-Sukenik-1999" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.01.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>1 month follow-up</NAME>
<CONT_DATA CI_END="2.1462674732901377" CI_START="-2.7462674732901355" EFFECT_SIZE="-0.29999999999999893" ESTIMABLE="YES" MEAN_1="11.9" MEAN_2="12.2" ORDER="5922" SD_1="2.72" SD_2="2.86" SE="1.2481185841096991" STUDY_ID="STD-Sukenik-1999" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.01.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>3 month follow-up</NAME>
<CONT_DATA CI_END="2.79977472647814" CI_START="-1.5997747264781408" EFFECT_SIZE="0.5999999999999996" ESTIMABLE="YES" MEAN_1="12.9" MEAN_2="12.3" ORDER="5923" SD_1="2.28" SD_2="2.72" SE="1.122354667651897" STUDY_ID="STD-Sukenik-1999" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.02" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="30" TOTAL_2="30" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain (10 cm VAS)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Sulphur</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Dead Sea</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.02.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>End of treatment</NAME>
<CONT_DATA CI_END="1.725957080650288" CI_START="-0.725957080650288" EFFECT_SIZE="0.5" ESTIMABLE="YES" MEAN_1="5.9" MEAN_2="5.4" ORDER="5924" SD_1="1.19" SD_2="1.58" SE="0.6254998001598402" STUDY_ID="STD-Sukenik-1999" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.02.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>1 month follow-up</NAME>
<CONT_DATA CI_END="0.9887624941646276" CI_START="-0.9887624941646276" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="5.5" MEAN_2="5.5" ORDER="5925" SD_1="0.85" SD_2="1.35" SE="0.5044799302251776" STUDY_ID="STD-Sukenik-1999" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.02.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>3 month follow-up</NAME>
<CONT_DATA CI_END="1.3036007063703217" CI_START="-0.9036007063703213" EFFECT_SIZE="0.20000000000000018" ESTIMABLE="YES" MEAN_1="6.3" MEAN_2="6.1" ORDER="5926" SD_1="1.48" SD_2="0.99" SE="0.5630719314616917" STUDY_ID="STD-Sukenik-1999" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" NO="3">
<NAME>Tapwater baths additional on exercises</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-003.01" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="24" TOTAL_2="23" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Stiffness</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="42.723684612984115" CI_START="-4.383684612984116" EFFECT_SIZE="19.17" ESTIMABLE="YES" MEAN_1="67.0" MEAN_2="47.83" ORDER="5927" SD_1="50.46" SD_2="29.69" SE="12.017406849703656" STUDY_ID="STD-Green-1993" TOTAL_1="24" TOTAL_2="23" WEIGHT="0.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" NO="4">
<NAME>Tap water baths versus exercises</NAME>
</COMPARISON>
<COMPARISON ID="CMP-005" NO="5">
<NAME>Sulphur baths versus no treatment</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.01" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="30" TOTAL_2="27" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain (10 cm VAS)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Sulphur</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no treatment</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.01.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="9" WEIGHT="0.0" Z="0.0">
<NAME>End of treatment</NAME>
<CONT_DATA CI_END="0.776393234329144" CI_START="-1.3763932343291436" EFFECT_SIZE="-0.2999999999999998" ESTIMABLE="YES" MEAN_1="5.9" MEAN_2="6.2" ORDER="5928" SD_1="1.19" SD_2="1.2" SE="0.5491903130973815" STUDY_ID="STD-Sukenik-1999" TOTAL_1="10" TOTAL_2="9" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.01.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="9" WEIGHT="0.0" Z="0.0">
<NAME>1 month follow-up</NAME>
<CONT_DATA CI_END="0.32834868795228433" CI_START="-1.5283486879522836" EFFECT_SIZE="-0.5999999999999996" ESTIMABLE="YES" MEAN_1="5.5" MEAN_2="6.1" ORDER="5929" SD_1="0.85" SD_2="1.17" SE="0.47365599331160163" STUDY_ID="STD-Sukenik-1999" TOTAL_1="10" TOTAL_2="9" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.01.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="9" WEIGHT="0.0" Z="0.0">
<NAME>3 month follow-up</NAME>
<CONT_DATA CI_END="0.9470877443098527" CI_START="-1.7470877443098516" EFFECT_SIZE="-0.39999999999999947" ESTIMABLE="YES" MEAN_1="6.2" MEAN_2="6.6" ORDER="5930" SD_1="1.48" SD_2="1.51" SE="0.6873022948051639" STUDY_ID="STD-Sukenik-1999" TOTAL_1="10" TOTAL_2="9" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.02" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="30" TOTAL_2="27" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Function</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Sulphur</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no treatment</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.02.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="9" WEIGHT="0.0" Z="0.0">
<NAME>End of treatment</NAME>
<CONT_DATA CI_END="1.354262051158221" CI_START="-2.154262051158222" EFFECT_SIZE="-0.40000000000000036" ESTIMABLE="YES" MEAN_1="12.0" MEAN_2="12.4" ORDER="5931" SD_1="2.0" SD_2="1.9" SE="0.8950481054731702" STUDY_ID="STD-Sukenik-1999" TOTAL_1="10" TOTAL_2="9" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.02.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="9" WEIGHT="0.0" Z="0.0">
<NAME>1 month follow-up</NAME>
<CONT_DATA CI_END="0.922566959676427" CI_START="-5.122566959676426" EFFECT_SIZE="-2.0999999999999996" ESTIMABLE="YES" MEAN_1="11.9" MEAN_2="14.0" ORDER="5932" SD_1="2.72" SD_2="3.84" SE="1.5421543372827506" STUDY_ID="STD-Sukenik-1999" TOTAL_1="10" TOTAL_2="9" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.02.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="9" WEIGHT="0.0" Z="0.0">
<NAME>3 month follow-up</NAME>
<CONT_DATA CI_END="1.6550460482146985" CI_START="-3.8550460482146978" EFFECT_SIZE="-1.0999999999999996" ESTIMABLE="YES" MEAN_1="12.9" MEAN_2="14.0" ORDER="5933" SD_1="2.28" SD_2="3.62" SE="1.405661568246228" STUDY_ID="STD-Sukenik-1999" TOTAL_1="10" TOTAL_2="9" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" NO="6">
<NAME>Dead Sea baths versus no treatment</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-006.01" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="30" TOTAL_2="27" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain (10 cm VAS)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Dead Sea</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no treatment</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.01.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="9" WEIGHT="0.0" Z="0.0">
<NAME>End of treatment</NAME>
<CONT_DATA CI_END="3.454438197484891" CI_START="0.9455618025151096" EFFECT_SIZE="2.2" ESTIMABLE="YES" MEAN_1="5.4" MEAN_2="3.2" ORDER="5934" SD_1="1.58" SD_2="1.2" SE="0.6400312492370978" STUDY_ID="STD-Sukenik-1999" TOTAL_1="10" TOTAL_2="9" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.01.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="9" WEIGHT="0.0" Z="0.0">
<NAME>1 month follow-up</NAME>
<CONT_DATA CI_END="0.5333100885014137" CI_START="-1.733310088501413" EFFECT_SIZE="-0.5999999999999996" ESTIMABLE="YES" MEAN_1="5.5" MEAN_2="6.1" ORDER="5935" SD_1="1.35" SD_2="1.17" SE="0.5782300580218915" STUDY_ID="STD-Sukenik-1999" TOTAL_1="10" TOTAL_2="9" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.01.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="9" WEIGHT="0.0" Z="0.0">
<NAME>3 month follow-up</NAME>
<CONT_DATA CI_END="0.6617717632139262" CI_START="-1.6617717632139262" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="6.1" MEAN_2="6.6" ORDER="5936" SD_1="0.99" SD_2="1.51" SE="0.5927515874668278" STUDY_ID="STD-Sukenik-1999" TOTAL_1="10" TOTAL_2="9" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-006.02" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="30" TOTAL_2="27" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Function</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Dead Sea</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no treatment</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.02.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="9" WEIGHT="0.0" Z="0.0">
<NAME>End of treatment</NAME>
<CONT_DATA CI_END="2.800730471850468" CI_START="-3.600730471850469" EFFECT_SIZE="-0.40000000000000036" ESTIMABLE="YES" MEAN_1="12.0" MEAN_2="12.4" ORDER="5937" SD_1="4.76" SD_2="1.9" SE="1.6330557587269061" STUDY_ID="STD-Sukenik-1999" TOTAL_1="10" TOTAL_2="9" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.02.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="9" WEIGHT="0.0" Z="0.0">
<NAME>1 month follow-up</NAME>
<CONT_DATA CI_END="1.2718082278684357" CI_START="-4.871808227868437" EFFECT_SIZE="-1.8000000000000007" ESTIMABLE="YES" MEAN_1="12.2" MEAN_2="14.0" ORDER="5938" SD_1="2.86" SD_2="3.84" SE="1.5672778949503499" STUDY_ID="STD-Sukenik-1999" TOTAL_1="10" TOTAL_2="9" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.02.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="9" WEIGHT="0.0" Z="0.0">
<NAME>3 month follow-up</NAME>
<CONT_DATA CI_END="1.200782747283872" CI_START="-4.600782747283871" EFFECT_SIZE="-1.6999999999999993" ESTIMABLE="YES" MEAN_1="12.3" MEAN_2="14.0" ORDER="5939" SD_1="2.71" SD_2="3.62" SE="1.4800183932790987" STUDY_ID="STD-Sukenik-1999" TOTAL_1="10" TOTAL_2="9" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" NO="7">
<NAME>Sulphur + Dead Sea baths versus no treatment</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-007.01" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="21" TOTAL_2="27" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain (10 cm VAS)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours baths</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no treatment</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.01.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="7" TOTAL_2="9" WEIGHT="0.0" Z="0.0">
<NAME>End of treatment</NAME>
<CONT_DATA CI_END="-1.1461242615048535" CI_START="-3.8538757384951463" EFFECT_SIZE="-2.5" ESTIMABLE="YES" MEAN_1="3.7" MEAN_2="6.2" ORDER="5940" SD_1="1.49" SD_2="1.2" SE="0.6907656207840275" STUDY_ID="STD-Sukenik-1999" TOTAL_1="7" TOTAL_2="9" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.01.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="7" TOTAL_2="9" WEIGHT="0.0" Z="0.0">
<NAME>1 month follow-up</NAME>
<CONT_DATA CI_END="-0.5992692335957828" CI_START="-3.000730766404217" EFFECT_SIZE="-1.7999999999999998" ESTIMABLE="YES" MEAN_1="4.3" MEAN_2="6.1" ORDER="5941" SD_1="1.25" SD_2="1.17" SE="0.6126289951628846" STUDY_ID="STD-Sukenik-1999" TOTAL_1="7" TOTAL_2="9" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.01.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="7" TOTAL_2="9" WEIGHT="0.0" Z="0.0">
<NAME>3 month follow-up</NAME>
<CONT_DATA CI_END="0.6997455934929504" CI_START="-2.4997455934929493" EFFECT_SIZE="-0.8999999999999995" ESTIMABLE="YES" MEAN_1="5.7" MEAN_2="6.6" ORDER="5942" SD_1="1.7" SD_2="1.51" SE="0.81621172945602" STUDY_ID="STD-Sukenik-1999" TOTAL_1="7" TOTAL_2="9" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-007.02" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="21" TOTAL_2="27" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Function</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours baths</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no treatment</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.02.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="7" TOTAL_2="9" WEIGHT="0.0" Z="0.0">
<NAME>End of treatment</NAME>
<CONT_DATA CI_END="-3.3144184583660374" CI_START="-8.085581541633964" EFFECT_SIZE="-5.7" ESTIMABLE="YES" MEAN_1="6.7" MEAN_2="12.4" ORDER="5943" SD_1="2.75" SD_2="1.9" SE="1.2171558051327094" STUDY_ID="STD-Sukenik-1999" TOTAL_1="7" TOTAL_2="9" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.02.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="7" TOTAL_2="9" WEIGHT="0.0" Z="0.0">
<NAME>1 month follow-up</NAME>
<CONT_DATA CI_END="1.9554501985905928" CI_START="-6.555450198590594" EFFECT_SIZE="-2.3000000000000007" ESTIMABLE="YES" MEAN_1="11.7" MEAN_2="14.0" ORDER="5944" SD_1="4.64" SD_2="3.84" SE="2.1711879565936116" STUDY_ID="STD-Sukenik-1999" TOTAL_1="7" TOTAL_2="9" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.02.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="7" TOTAL_2="9" WEIGHT="0.0" Z="0.0">
<NAME>3 month follow-up</NAME>
<CONT_DATA CI_END="1.116497737553662" CI_START="-6.316497737553661" EFFECT_SIZE="-2.5999999999999996" ESTIMABLE="YES" MEAN_1="11.4" MEAN_2="14.0" ORDER="5945" SD_1="3.87" SD_2="3.62" SE="1.8962071583299087" STUDY_ID="STD-Sukenik-1999" TOTAL_1="7" TOTAL_2="9" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-008" NO="8">
<NAME>Mineral baths versus no treatment</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-008.01" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="4.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="278" TOTAL_2="242" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain (100 mm VAS)</NAME>
<GROUP_LABEL_1>Baths</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours mineral bath</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no treatmen</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.01.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="24" WEIGHT="0.0" Z="0.0">
<NAME>End of treatment</NAME>
<CONT_DATA CI_END="-1.2448085412188759" CI_START="-2.4003821854920986" EFFECT_SIZE="-1.8225953633554872" ESTIMABLE="YES" MEAN_1="22.1" MEAN_2="63.8" ORDER="5946" SD_1="22.3" SD_2="23.3" SE="0.2947946118878306" STUDY_ID="STD-Tishler-2004" TOTAL_1="48" TOTAL_2="24" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="1.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.01.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="139" TOTAL_2="121" WEIGHT="0.0" Z="0.0">
<NAME>1 month follow-up</NAME>
<CONT_DATA CI_END="-0.21457494078943368" CI_START="-0.7958844855304428" EFFECT_SIZE="-0.5052297131599383" ESTIMABLE="YES" MEAN_1="35.0" MEAN_2="48.0" ORDER="5947" SD_1="29.0" SD_2="22.0" SE="0.14829597618280352" STUDY_ID="STD-Nguyen-1997" TOTAL_1="91" TOTAL_2="97" WEIGHT="0.0"/>
<CONT_DATA CI_END="-1.0729594376050997" CI_START="-2.196348312490595" EFFECT_SIZE="-1.6346538750478474" ESTIMABLE="YES" MEAN_1="26.5" MEAN_2="63.9" ORDER="5948" SD_1="22.3" SD_2="23.3" SE="0.28658406066301306" STUDY_ID="STD-Tishler-2004" TOTAL_1="48" TOTAL_2="24" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.01.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="91" TOTAL_2="97" WEIGHT="0.0" Z="0.0">
<NAME>6 month follow-up</NAME>
<CONT_DATA CI_END="-0.056398051111303193" CI_START="-0.632785527478591" EFFECT_SIZE="-0.34459178929494705" ESTIMABLE="YES" MEAN_1="41.0" MEAN_2="50.0" ORDER="5949" SD_1="28.0" SD_2="24.0" SE="0.14704032342271556" STUDY_ID="STD-Nguyen-1997" TOTAL_1="91" TOTAL_2="97" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-008.02" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="1.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="182" TOTAL_2="194" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Quality of life</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours mineral bath</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no treatment</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.02.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="91" TOTAL_2="97" WEIGHT="0.0" Z="0.0">
<NAME>1 month follow-up</NAME>
<CONT_DATA CI_END="-0.013964160551479698" CI_START="-0.5860358394485199" EFFECT_SIZE="-0.2999999999999998" ESTIMABLE="YES" MEAN_1="2.6" MEAN_2="2.9" ORDER="5950" SD_1="1.0" SD_2="1.0" SE="0.14593933444937474" STUDY_ID="STD-Nguyen-1997" TOTAL_1="91" TOTAL_2="97" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.02.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="91" TOTAL_2="97" WEIGHT="0.0" Z="0.0">
<NAME>6 month follow-up</NAME>
<CONT_DATA CI_END="-0.11396416055147979" CI_START="-0.68603583944852" EFFECT_SIZE="-0.3999999999999999" ESTIMABLE="YES" MEAN_1="2.5" MEAN_2="2.9" ORDER="5951" SD_1="1.0" SD_2="1.0" SE="0.14593933444937474" STUDY_ID="STD-Nguyen-1997" TOTAL_1="91" TOTAL_2="97" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-008.03" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="182" TOTAL_2="194" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Analgesic intake</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours mineral bath</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no treatment</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.03.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>End of treatment</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.03.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="91" TOTAL_2="97" WEIGHT="0.0" Z="0.0">
<NAME>1 month follow-up</NAME>
<CONT_DATA CI_END="-6.385965643039163" CI_START="-21.614034356960836" EFFECT_SIZE="-14.0" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="21.0" ORDER="5952" SD_1="23.0" SD_2="30.0" SE="3.8847827904080727" STUDY_ID="STD-Nguyen-1997" TOTAL_1="91" TOTAL_2="97" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-008.03.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="91" TOTAL_2="97" WEIGHT="0.0" Z="0.0">
<NAME>6 month follow-up</NAME>
<CONT_DATA CI_END="-0.3859656430391629" CI_START="-15.614034356960836" EFFECT_SIZE="-8.0" ESTIMABLE="YES" MEAN_1="12.0" MEAN_2="20.0" ORDER="5953" SD_1="23.0" SD_2="30.0" SE="3.8847827904080727" STUDY_ID="STD-Nguyen-1997" TOTAL_1="91" TOTAL_2="97" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="20" I2="0.0" I2_Q="0.0" ID="CMP-008.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="44" TOTAL_2="24" WEIGHT="0.0" Z="0.0">
<NAME>Analgesic intake</NAME>
<GROUP_LABEL_1>Mineral baths</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours baths</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.21375786811881187" CI_START="0.013918582916987911" EFFECT_SIZE="0.05454545454545454" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="20" LOG_CI_END="-0.6700778905521019" LOG_CI_START="-1.8564049789970607" LOG_EFFECT_SIZE="-1.2632414347745815" ORDER="5954" O_E="0.0" SE="0.6968544041663658" STUDY_ID="STD-Tishler-2004" TOTAL_1="44" TOTAL_2="24" VAR="0.48560606060606065" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES/>
<EXTENSIONS/>
</COCHRANE_REVIEW>